data_1yjj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yjj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.675 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.424 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.665 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.696 HD22 ' NE2' ' A' ' 87' ' ' GLN . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.665 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.696 ' NE2' HD22 ' A' ' 64' ' ' ASN . 15.9 mm100 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 88' ' ' ILE . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.489 ' C ' ' HG1' ' A' ' 75' ' ' THR . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.708 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.664 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CB ' ' SG ' ' A' ' 85' ' ' CYS . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.664 ' H ' ' HG ' ' A' ' 22' ' ' SER . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.745 0.783 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.423 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.471 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.655 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.46 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' H ' ' HG ' ' A' ' 22' ' ' SER . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.465 0.65 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HB3' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.476 HH11 ' HB3' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 88' ' ' ILE . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.764 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.422 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.422 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.454 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.046 0.451 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.49 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.431 ' HG1' ' N ' ' A' ' 58' ' ' ASP . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' N ' ' HG1' ' A' ' 57' ' ' THR . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.656 ' ND2' HE22 ' A' ' 87' ' ' GLN . 0.3 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.437 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.656 HE22 ' ND2' ' A' ' 64' ' ' ASN . 5.9 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' A' ' 92' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.688 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.533 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.533 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 49' ' ' HIS . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.413 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.515 ' C ' ' HG ' ' A' ' 1' ' ' SER . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.54 ' N ' ' HG ' ' A' ' 1' ' ' SER . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.4 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.694 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.553 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.11 0.481 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.647 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.468 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.475 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.493 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.647 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.43 ' OXT' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.699 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.073 0.463 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.493 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.447 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.41 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 24' ' ' MET . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 88' ' ' ILE . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HZ2' ' CD ' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.708 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' CD ' ' HZ2' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 121.35 0.595 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.496 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.452 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.553 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.433 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.68 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 67' ' ' GLU . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.68 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.538 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.699 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.419 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.422 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' H ' ' HG ' ' A' ' 22' ' ' SER . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m-80 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.419 HG23 HH11 ' A' ' 13' ' ' ARG . 4.3 mt . . . . . 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.528 0.68 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.464 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.584 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 62' ' ' ALA . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.669 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.584 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.669 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 97' ' ' ILE . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.515 ' HG ' ' C ' ' A' ' 91' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.775 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.487 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.487 ' H ' ' HG ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.6 mt . . . . . 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.498 0.666 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.66 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.515 ' C ' ' HG ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.462 ' N ' ' HG ' ' A' ' 1' ' ' SER . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 105' ' ' GLN . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.658 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.417 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' NH1' HG12 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.566 ' HG ' ' NE2' ' A' ' 25' ' ' GLN . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.566 ' NE2' ' HG ' ' A' ' 22' ' ' SER . 30.6 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.433 HG12 ' NH1' ' A' ' 13' ' ' ARG . 83.9 mt . . . . . 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 2.9 p . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.46 0.647 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.465 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.482 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.564 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.564 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.418 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.44 ' OE1' ' OD1' ' A' ' 64' ' ' ASN . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 95' ' ' ASP . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.668 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.436 ' CG2' ' NH1' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.436 ' NH1' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' A' ' 14' ' ' GLU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.53 ' H ' ' HG ' ' A' ' 22' ' ' SER . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 27' ' ' ALA . 5.4 m-80 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 4.4 p . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.357 0.598 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.453 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.491 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.743 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.401 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' CYS . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.432 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.498 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.401 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.743 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.498 ' C ' ' HG1' ' A' ' 75' ' ' THR . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.657 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 14' ' ' GLU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 1' ' ' SER . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.421 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 55' ' ' ALA . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.694 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.413 HH11 ' CD1' ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.443 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.459 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.62 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 14' ' ' GLU . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.776 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt . . . . . 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.52 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.414 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 73' ' ' CYS . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.464 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.415 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.532 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.712 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.415 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.423 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.687 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.591 0.71 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.472 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.443 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.59 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.5 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.675 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.5 mt -108.83 -29.61 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -70.36 5.48 1.73 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.146 -0.972 . . . . 0.0 113.548 -177.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.28 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 120.505 1.502 . . . . 0.0 111.725 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.796 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.8 pt -99.8 10.54 7.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.9 t 54.62 62.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.47 111.57 1.08 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 40' ' ' GLY . 14.8 t70 -68.02 -64.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.266 -1.137 . . . . 0.0 109.616 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.5 p -64.24 -2.87 2.35 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.79 -1.194 . . . . 0.0 109.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 71.93 13.78 75.75 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.785 -1.197 . . . . 0.0 110.227 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 20.27 26.95 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -98.18 15.91 22.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.236 -1.155 . . . . 0.0 108.152 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.19 65.14 1.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.46 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.73 18.45 1.29 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.288 -0.882 . . . . 0.0 109.306 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p -148.08 -169.97 3.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.067 -1.021 . . . . 0.0 109.074 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.665 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.696 HD22 ' NE2' ' A' ' 87' ' ' GLN . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.665 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.696 ' NE2' HD22 ' A' ' 64' ' ' ASN . 15.9 mm100 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 88' ' ' ILE . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.489 ' C ' ' HG1' ' A' ' 75' ' ' THR . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.485 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.708 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.664 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' CB ' ' SG ' ' A' ' 85' ' ' CYS . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.664 ' H ' ' HG ' ' A' ' 22' ' ' SER . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.8 mt -115.77 -63.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' OH ' ' CG1' ' A' ' 50' ' ' VAL . 11.6 m-85 -89.14 8.36 30.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.746 -1.221 . . . . 0.0 110.841 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 1.6 p-10 -59.24 -99.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.613 -1.304 . . . . 0.0 109.194 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 1.2 tp 31.52 85.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.985 0.898 . . . . 0.0 109.914 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.5 t 52.9 98.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.827 -1.171 . . . . 0.0 109.519 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.03 123.45 7.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -72.61 0.17 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -1.161 . . . . 0.0 110.565 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.9 p -104.41 1.94 30.64 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.49 -4.16 21.56 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.579 -1.296 . . . . 0.0 109.939 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.59 31.59 3.92 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.379 -1.071 . . . . 0.0 110.479 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.7 t -98.82 20.72 12.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.9 . . . . 0.0 108.646 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.97 62.72 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.607 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -146.95 4.72 0.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.3 p -142.46 -168.51 2.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.064 -1.023 . . . . 0.0 109.523 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.423 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.471 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.655 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.46 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' H ' ' HG ' ' A' ' 22' ' ' SER . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.51 -52.46 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' OH ' ' CG1' ' A' ' 50' ' ' VAL . 9.5 m-85 -106.04 6.38 31.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.82 -1.175 . . . . 0.0 110.225 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 2.9 p-10 -56.84 -98.72 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.629 -1.294 . . . . 0.0 110.04 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.537 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 19.7 mm 44.71 59.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 61.58 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.347 -0.846 . . . . 0.0 109.317 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.45 8.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' OD2' ' OG1' ' A' ' 47' ' ' THR . 33.9 m-20 -70.94 -73.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 110.272 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.4 p -94.15 -8.59 39.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.114 -0.991 . . . . 0.0 110.234 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.23 19.62 79.69 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.97 72.77 1.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 42' ' ' SER . 1.3 t -143.84 11.49 1.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.239 -1.153 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.99 55.09 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.284 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 p -148.55 21.28 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 110.081 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.13 163.06 37.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.953 -1.092 . . . . 0.0 109.402 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.419 ' OG1' ' OD2' ' A' ' 38' ' ' ASP . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HB3' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.476 HH11 ' HB3' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 88' ' ' ILE . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.568 ' S2 ' ' SD ' ' A' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.764 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.422 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.422 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.454 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.9 mt -114.49 -26.72 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.868 ' O ' ' N ' ' A' ' 35' ' ' ILE . 1.9 t80 -73.04 3.09 5.84 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.096 -1.002 . . . . 0.0 112.796 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.65 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 CA-C-N 120.318 1.417 . . . . 0.0 111.804 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.868 ' N ' ' O ' ' A' ' 33' ' ' TYR . 16.0 tt -100.83 162.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -43.71 -40.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.07 66.88 2.39 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.416 ' OD1' ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -68.62 -71.87 0.2 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -1.117 . . . . 0.0 110.369 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.1 p -79.84 3.97 18.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.061 -1.024 . . . . 0.0 110.182 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.45 25.24 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.96 26.76 5.93 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.449 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.6 t -98.53 22.26 10.09 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.083 -1.245 . . . . 0.0 109.048 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.29 62.12 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.554 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 19.31 1.26 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.871 . . . . 0.0 109.131 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p -157.1 -169.77 3.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -0.853 . . . . 0.0 109.875 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.416 ' OG1' ' OD1' ' A' ' 38' ' ' ASP . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.49 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.431 ' HG1' ' N ' ' A' ' 58' ' ' ASP . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' N ' ' HG1' ' A' ' 57' ' ' THR . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.656 ' ND2' HE22 ' A' ' 87' ' ' GLN . 0.3 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.437 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.656 HE22 ' ND2' ' A' ' 64' ' ' ASN . 5.9 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' A' ' 92' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.688 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.533 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.605 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.533 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.1 mt -115.22 -35.99 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.857 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.83 10.38 1.45 Allowed 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.144 -0.973 . . . . 0.0 111.94 -176.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.1 53.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.909 1.231 . . . . 0.0 111.641 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.857 ' N ' ' O ' ' A' ' 33' ' ' TYR . 36.3 mt -104.58 -83.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p -172.38 129.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.125 -0.984 . . . . 0.0 109.307 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.08 64.17 4.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.13 -72.22 0.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.189 -1.183 . . . . 0.0 109.837 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.6 p -96.24 -15.07 22.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 0.0 109.539 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.05 15.96 74.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.9 16.55 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -98.62 17.09 19.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.225 -1.162 . . . . 0.0 108.901 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.2 66.46 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.463 -0.773 . . . . 0.0 109.946 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.19 5.81 0.98 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.0 p -143.86 -175.52 4.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 0.0 108.897 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.507 ' HG1' ' CG2' ' A' ' 35' ' ' ILE . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.413 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.476 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.515 ' C ' ' HG ' ' A' ' 1' ' ' SER . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.54 ' N ' ' HG ' ' A' ' 1' ' ' SER . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.4 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.694 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.553 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mt -114.84 -65.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.615 ' HH ' ' CG2' ' A' ' 101' ' ' VAL . 15.7 m-85 -89.95 9.32 28.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.926 -1.109 . . . . 0.0 111.458 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 2.9 p-10 -57.71 -100.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.164 -1.585 . . . . 0.0 110.434 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.523 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 17.7 mm 40.88 54.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 63.19 107.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.286 -0.884 . . . . 0.0 109.243 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.84 132.09 10.85 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.03 -72.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.275 . . . . 0.0 109.863 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -98.55 5.67 47.71 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.055 -1.028 . . . . 0.0 110.523 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.78 -4.22 16.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.1 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.1 29.28 4.93 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 50.7 m -98.5 22.46 9.78 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.482 -1.011 . . . . 0.0 108.965 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.34 61.04 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -147.04 18.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 109.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.0 -168.84 2.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.822 -1.174 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.647 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.475 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.468 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.475 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.493 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.647 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.615 ' CG2' ' HH ' ' A' ' 33' ' ' TYR . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.43 ' OXT' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.699 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.81 -63.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 34' ' ' ASP . 25.0 m-85 -90.34 8.27 34.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.658 -1.276 . . . . 0.0 111.13 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 1.6 p-10 -55.04 -98.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.535 -1.353 . . . . 0.0 109.22 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 3.2 tt 33.11 88.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 35' ' ' ILE . 9.2 p 28.46 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.104 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.42 138.94 19.12 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.27 -72.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.609 -0.936 . . . . 0.0 109.728 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.8 p -95.23 -3.02 48.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.464 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.87 60.09 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.65 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.07 25.84 6.28 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 121.232 -1.158 . . . . 0.0 110.326 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -98.01 18.26 16.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -1.154 . . . . 0.0 109.084 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.12 58.61 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.075 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t -146.87 18.72 1.27 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.091 -1.006 . . . . 0.0 109.902 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p -154.04 -168.46 2.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 0.0 109.813 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.493 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.447 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.41 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 24' ' ' MET . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 88' ' ' ILE . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HZ2' ' CD ' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.708 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' CD ' ' HZ2' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.401 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt -112.24 -38.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.23 13.69 0.08 Allowed 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.302 -0.874 . . . . 0.0 112.764 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.33 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 120.061 1.3 . . . . 0.0 111.576 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.828 ' N ' ' O ' ' A' ' 33' ' ' TYR . 26.2 mt -105.29 11.45 8.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t 56.09 78.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.654 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.09 108.27 2.42 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -68.0 -65.24 0.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -1.071 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.1 p -66.27 -5.02 9.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.49 6.76 62.88 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 104.71 21.57 9.06 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.8 t -97.94 19.81 13.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.974 -1.309 . . . . 0.0 109.304 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.79 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -0.795 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.45 16.2 1.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.048 . . . . 0.0 109.829 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p -146.78 -168.71 3.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.963 -1.085 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.496 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.452 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.433 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.68 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 67' ' ' GLU . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.553 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.68 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.538 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.699 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.419 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.422 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' H ' ' HG ' ' A' ' 22' ' ' SER . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m-80 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.419 HG23 HH11 ' A' ' 13' ' ' ARG . 4.3 mt -110.78 -61.19 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.736 ' O ' ' N ' ' A' ' 35' ' ' ILE . 35.6 m-85 -82.86 24.71 0.72 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.758 -1.214 . . . . 0.0 112.541 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 27.9 p-10 -47.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.103 1.43 . . . . 0.0 111.023 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.736 ' N ' ' O ' ' A' ' 33' ' ' TYR . 47.5 mm -128.08 157.06 40.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 113.688 -1.597 . . . . 0.0 110.354 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -42.62 -32.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 110.508 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 49.43 89.75 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -67.38 -69.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -1.093 . . . . 0.0 110.157 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.1 p -68.4 -0.03 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 109.918 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.85 4.81 59.66 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.24 23.2 8.63 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 9.3 p -98.24 19.89 13.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.697 -0.884 . . . . 0.0 109.537 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.53 60.05 3.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 109.752 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.21 20.31 1.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p -153.47 -175.31 5.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.172 -0.955 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.464 ' CE1' ' CZ ' ' A' ' 51' ' ' TYR . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 62' ' ' ALA . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.669 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' HE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.584 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.669 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 97' ' ' ILE . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.515 ' HG ' ' C ' ' A' ' 91' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.775 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.487 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.556 ' SD ' ' CE2' ' A' ' 33' ' ' TYR . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.487 ' H ' ' HG ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.6 mt -116.44 -31.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.793 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -63.67 9.32 0.06 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.253 -0.904 . . . . 0.0 112.813 -176.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.06 35.62 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.683 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.793 ' N ' ' O ' ' A' ' 33' ' ' TYR . 10.9 pt -102.1 14.37 5.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.7 t 57.83 97.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.611 -0.681 . . . . 0.0 109.616 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.36 100.7 2.55 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 -68.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -1.144 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.3 p -64.49 -6.57 7.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.46 18.05 76.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 22.48 28.76 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.438 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.5 t -98.29 13.8 30.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.422 -1.046 . . . . 0.0 108.806 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.44 61.56 2.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.476 -0.765 . . . . 0.0 109.806 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.84 10.24 1.04 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.104 -0.998 . . . . 0.0 109.69 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p -137.93 -168.45 2.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.342 -0.849 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.66 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.515 ' C ' ' HG ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.462 ' N ' ' HG ' ' A' ' 1' ' ' SER . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 105' ' ' GLN . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.658 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.417 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' NH1' HG12 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.566 ' HG ' ' NE2' ' A' ' 25' ' ' GLN . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.438 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' NE2' ' HG ' ' A' ' 22' ' ' SER . 30.6 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.433 HG12 ' NH1' ' A' ' 13' ' ' ARG . 83.9 mt -118.78 -55.08 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 9.38 25.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.3 -0.875 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 36' ' ' VAL . 2.0 p-10 -57.75 -98.19 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.572 -1.33 . . . . 0.0 109.225 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 15.2 mm 61.0 -67.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.272 0.558 . . . . 0.0 109.543 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 34' ' ' ASP . 40.8 t -142.34 -74.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.021 -1.049 . . . . 0.0 108.91 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.12 98.76 0.69 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.78 -72.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 110.461 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.2 p -73.46 -14.72 61.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.677 -1.265 . . . . 0.0 110.018 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.69 22.96 78.15 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.438 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 91.24 19.4 42.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.425 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 3.4 m -95.37 12.75 28.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -1.11 . . . . 0.0 108.859 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.28 2.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.0 109.57 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.64 19.27 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -148.66 177.25 9.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.851 -1.155 . . . . 0.0 109.549 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.482 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.564 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.564 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.418 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.44 ' OE1' ' OD1' ' A' ' 64' ' ' ASN . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 95' ' ' ASP . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.494 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.668 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.436 ' CG2' ' NH1' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.436 ' NH1' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' A' ' 14' ' ' GLU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.53 ' H ' ' HG ' ' A' ' 22' ' ' SER . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 27' ' ' ALA . 5.4 m-80 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.4 mt -115.99 -60.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.546 ' OH ' ' CG1' ' A' ' 50' ' ' VAL . 1.7 t80 -87.33 5.34 39.0 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.82 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.4 p-10 -61.5 -91.31 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 109.411 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.506 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 26.2 mt 48.24 -82.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 34' ' ' ASP . 4.4 m -133.37 -166.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.101 -1.0 . . . . 0.0 108.881 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.07 95.63 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -68.22 -71.9 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -1.138 . . . . 0.0 110.972 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.1 p -74.71 2.8 9.14 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.035 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.95 -1.63 30.7 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 25.63 6.3 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.461 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 t -98.55 25.45 6.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -1.172 . . . . 0.0 109.191 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.15 60.62 3.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.75 17.67 1.28 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 4.4 p -150.99 -168.53 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.453 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.491 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.743 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' CYS . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.432 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.498 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.401 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.743 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.406 HG12 ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.498 ' C ' ' HG1' ' A' ' 75' ' ' THR . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.657 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 14' ' ' GLU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 1' ' ' SER . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -114.14 -63.09 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 34' ' ' ASP . 12.6 m-85 -89.18 8.84 28.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.834 -1.166 . . . . 0.0 111.931 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 1.8 p-10 -57.37 -100.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.064 -1.647 . . . . 0.0 109.62 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 1.6 pt 28.92 -90.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 121.262 0.554 . . . . 0.0 110.352 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 20.5 t -95.01 148.69 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 108.966 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.41 88.79 0.11 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.4 -71.91 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.177 -1.19 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 42' ' ' SER . 5.5 p -86.5 -5.39 59.16 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.116 -0.99 . . . . 0.0 110.228 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.14 6.15 64.0 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.671 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 22.13 8.12 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.505 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 11.7 t -97.83 18.74 15.1 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.115 -1.227 . . . . 0.0 109.114 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.42 57.72 3.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.02 24.0 1.18 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.987 -1.071 . . . . 0.0 109.51 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.7 p -157.69 -168.39 2.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.421 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 55' ' ' ALA . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.694 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.413 HH11 ' CD1' ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.443 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.459 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.62 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 14' ' ' GLU . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.776 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -115.14 -34.47 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.878 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -73.71 11.31 0.86 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.914 -1.117 . . . . 0.0 112.661 -176.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -49.42 52.21 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 119.891 1.223 . . . . 0.0 111.466 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.878 ' N ' ' O ' ' A' ' 33' ' ' TYR . 70.1 mt -113.09 154.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -65.85 67.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.962 -1.086 . . . . 0.0 109.59 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ILE . . . -57.22 96.43 0.05 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -67.45 -57.41 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -1.096 . . . . 0.0 109.758 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -80.95 -2.44 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.859 -1.151 . . . . 0.0 110.023 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.55 7.4 68.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.14 22.76 10.31 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 32.3 m -98.27 20.52 12.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -1.012 . . . . 0.0 108.919 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.23 62.69 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.947 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.53 8.78 1.03 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.054 . . . . 0.0 109.558 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p -140.24 -168.96 2.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.52 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.414 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 73' ' ' CYS . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.464 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.415 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.532 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.712 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.415 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.423 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.687 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.56 -40.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.15 2.05 42.65 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.281 -0.887 . . . . 0.0 111.299 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 36' ' ' VAL . 3.2 p-10 -70.56 -63.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 119.987 -1.696 . . . . 0.0 109.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 34' ' ' ASP . 17.4 tt -25.91 -38.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 34' ' ' ASP . 48.6 t -138.35 119.78 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.136 -0.977 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.47 101.18 0.21 Allowed Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -75.73 -75.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.882 -1.363 . . . . 0.0 111.24 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -86.74 -3.75 59.09 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.875 -1.14 . . . . 0.0 111.147 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.99 13.0 75.77 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.38 -1.39 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 24.27 20.13 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.157 -1.202 . . . . 0.0 110.81 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.6 t -89.69 20.24 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 108.811 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.21 58.69 5.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.7 . . . . 0.0 109.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -150.05 26.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.114 -0.991 . . . . 0.0 110.268 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p -161.47 -166.14 1.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.068 -1.02 . . . . 0.0 110.22 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.472 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.59 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.5 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.59 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' HD22 ' A' ' 15' ' ' LEU . 7.4 m120 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 15' ' ' LEU . 7.5 mt . . . . . 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 84' ' ' LEU . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 HD13 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.715 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.666 ' CD2' HD11 ' A' ' 78' ' ' LEU . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.521 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 48' ' ' CYS . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.511 HG23 HG11 ' A' ' 60' ' ' VAL . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 97' ' ' ILE . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD13 HG23 ' A' ' 60' ' ' VAL . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.556 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 HG21 ' A' ' 88' ' ' ILE . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 15' ' ' LEU . 5.8 mt . . . . . 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.745 0.783 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.474 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 97' ' ' ILE . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.689 HG12 ' HB1' ' A' ' 46' ' ' ALA . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 71' ' ' LEU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.416 HH22 ' HA ' ' A' ' 62' ' ' ALA . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' ILE . 19.9 mm-40 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 87' ' ' GLN . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.725 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 97' ' ' ILE . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' C ' HD23 ' A' ' 15' ' ' LEU . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 21' ' ' VAL . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 88' ' ' ILE . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.465 0.65 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.722 HG13 HD11 ' A' ' 97' ' ' ILE . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.737 HG23 ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HB2' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.407 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' LEU . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.488 HH11 ' HB2' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 88' ' ' ILE . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 23' ' ' LEU . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.533 ' SD ' HD21 ' A' ' 23' ' ' LEU . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.737 ' CD1' HG23 ' A' ' 60' ' ' VAL . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.669 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.434 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.434 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 24' ' ' MET . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 15' ' ' LEU . 67.9 mt . . . . . 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.046 0.451 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.596 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.939 HD22 ' CD ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.62 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 84' ' ' LEU . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.539 HG12 ' HB1' ' A' ' 46' ' ' ALA . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 83' ' ' ARG . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.939 ' CD ' HD22 ' A' ' 64' ' ' ASN . 31.5 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 60' ' ' VAL . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.644 ' CE ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 94' ' ' LEU . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.644 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.552 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 3' ' ' VAL . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 HH12 ' A' ' 13' ' ' ARG . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.481 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 24' ' ' MET . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 85' ' ' CYS . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 15' ' ' LEU . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 15' ' ' LEU . 79.1 mt . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' HG22 ' A' ' 47' ' ' THR . 2.0 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.558 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG13 HD11 ' A' ' 97' ' ' ILE . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 94' ' ' LEU . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 78' ' ' LEU . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.419 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 82' ' ' SER . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 23' ' ' LEU . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 60' ' ' VAL . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 18.3 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.575 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.674 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.674 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.63 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.548 HD11 HD21 ' A' ' 15' ' ' LEU . 17.5 mt . . . . . 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.11 0.481 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.572 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 94' ' ' LEU . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CB ' HD21 ' A' ' 94' ' ' LEU . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.481 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 78' ' ' LEU . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.53 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.572 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 84' ' ' LEU . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' SD ' ' A' ' 90' ' ' MET . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.696 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 21' ' ' VAL . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 17' ' ' VAL . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.604 HD11 HD21 ' A' ' 15' ' ' LEU . 3.7 mt . . . . . 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.436 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.073 0.463 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.555 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG12 HD22 ' A' ' 53' ' ' ASN . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 94' ' ' LEU . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 66' ' ' ARG . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 70' ' ' MET . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 82' ' ' SER . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 60' ' ' VAL . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' NZ ' ' OE1' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 17' ' ' VAL . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 90' ' ' MET . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.486 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 121.35 0.595 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 HG22 ' OXT' ' A' ' 106' ' ' TRP . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.75 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.676 HG13 HD11 ' A' ' 97' ' ' ILE . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CG ' HG12 ' A' ' 97' ' ' ILE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' LEU . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 60' ' ' VAL . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.676 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 82' ' ' SER . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 82' ' ' SER . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.679 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.676 HH21 ' N ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.676 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.596 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 97' ' ' ILE . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.535 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.485 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.657 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.748 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' ND2' HD22 ' A' ' 15' ' ' LEU . 7.2 m120 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.603 HD11 HD21 ' A' ' 15' ' ' LEU . 4.3 mt . . . . . 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.528 0.68 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.674 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.715 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 84' ' ' LEU . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 78' ' ' LEU . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' LEU . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 71' ' ' LEU . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.875 ' H ' HD23 ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 HG23 ' A' ' 60' ' ' VAL . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.629 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 HD21 ' A' ' 15' ' ' LEU . 28.6 mt . . . . . 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.498 0.666 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 97' ' ' ILE . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.663 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 71' ' ' LEU . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.663 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.438 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.431 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 1.4 tt0 -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 3' ' ' VAL . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 11' ' ' THR . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HD2' HD11 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' HD2' ' A' ' 13' ' ' ARG . 83.9 mt . . . . . 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.46 0.647 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 97' ' ' ILE . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.605 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 66' ' ' ARG . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 46' ' ' ALA . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 71' ' ' LEU . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.682 ' NE2' HD23 ' A' ' 84' ' ' LEU . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 84' ' ' LEU . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.703 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.498 ' N ' HD12 ' A' ' 97' ' ' ILE . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 HH12 ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 12' ' ' ARG . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.453 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 21' ' ' VAL . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 ' HB ' HG12 ' A' ' 17' ' ' VAL . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 27' ' ' ALA . 6.8 m120 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 15' ' ' LEU . 70.4 mt . . . . . 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.357 0.598 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 97' ' ' ILE . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' HD22 ' A' ' 94' ' ' LEU . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 94' ' ' LEU . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.783 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 78' ' ' LEU . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 71' ' ' LEU . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.783 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG23 HG11 ' A' ' 60' ' ' VAL . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.646 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.453 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 17' ' ' VAL . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 5.3 mt . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 94' ' ' LEU . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.732 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 1.2 p-10 -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.595 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 78' ' ' LEU . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.677 HH11 HD11 ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.537 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.677 HD11 HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 97' ' ' ILE . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.431 ' H ' ' HE3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 59' ' ' LYS . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.461 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.665 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.522 HG12 ' CE1' ' A' ' 5' ' ' TYR . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 3' ' ' VAL . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 32' ' ' ILE . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.515 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 15' ' ' LEU . 28.5 mt . . . . . 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 97' ' ' ILE . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.51 ' HB2' HD13 ' A' ' 97' ' ' ILE . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 78' ' ' LEU . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.413 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.494 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 71' ' ' LEU . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 84' ' ' LEU . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 60' ' ' VAL . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.849 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.757 HD12 HG23 ' A' ' 60' ' ' VAL . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.849 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.413 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG21 ' CG2' ' A' ' 17' ' ' VAL . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 11' ' ' THR . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 15' ' ' LEU . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 17' ' ' VAL . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 13' ' ' ARG . 96.8 mt . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.591 0.71 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 97' ' ' ILE . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 94' ' ' LEU . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CB ' HD21 ' A' ' 94' ' ' LEU . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 78' ' ' LEU . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 46' ' ' ALA . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.547 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 71' ' ' LEU . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.586 HG23 HG11 ' A' ' 60' ' ' VAL . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.912 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 56' ' ' PHE . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.912 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 ' HD2' ' A' ' 102' ' ' PRO . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 101' ' ' VAL . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.51 ' NE2' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.51 ' N ' ' NE2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.59 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' HD22 ' A' ' 15' ' ' LEU . 7.4 m120 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 15' ' ' LEU . 7.5 mt -108.83 -29.61 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -70.36 5.48 1.73 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.146 -0.972 . . . . 0.0 113.548 -177.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.28 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 120.505 1.502 . . . . 0.0 111.725 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.796 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.8 pt -99.8 10.54 7.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.9 t 54.62 62.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.47 111.57 1.08 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.02 -64.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.266 -1.137 . . . . 0.0 109.616 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.5 p -64.24 -2.87 2.35 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.79 -1.194 . . . . 0.0 109.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.93 13.78 75.75 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.785 -1.197 . . . . 0.0 110.227 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 20.27 26.95 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -98.18 15.91 22.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.236 -1.155 . . . . 0.0 108.152 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.19 65.14 1.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.46 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.73 18.45 1.29 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.288 -0.882 . . . . 0.0 109.306 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p -148.08 -169.97 3.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.067 -1.021 . . . . 0.0 109.074 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 84' ' ' LEU . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 HD13 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.715 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.666 ' CD2' HD11 ' A' ' 78' ' ' LEU . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.521 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 48' ' ' CYS . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.511 HG23 HG11 ' A' ' 60' ' ' VAL . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 97' ' ' ILE . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD13 HG23 ' A' ' 60' ' ' VAL . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.599 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.556 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.485 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 HG21 ' A' ' 88' ' ' ILE . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 15' ' ' LEU . 5.8 mt -115.77 -63.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' OH ' HG22 ' A' ' 101' ' ' VAL . 11.6 m-85 -89.14 8.36 30.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.746 -1.221 . . . . 0.0 110.841 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ILE . 1.6 p-10 -59.24 -99.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.613 -1.304 . . . . 0.0 109.194 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' ASP . 1.2 tp 31.52 85.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.985 0.898 . . . . 0.0 109.914 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.5 t 52.9 98.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.827 -1.171 . . . . 0.0 109.519 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.03 123.45 7.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -72.61 0.17 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -1.161 . . . . 0.0 110.565 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.9 p -104.41 1.94 30.64 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.49 -4.16 21.56 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.579 -1.296 . . . . 0.0 109.939 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.59 31.59 3.92 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.379 -1.071 . . . . 0.0 110.479 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.7 t -98.82 20.72 12.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.9 . . . . 0.0 108.646 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.97 62.72 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.607 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -146.95 4.72 0.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.3 p -142.46 -168.51 2.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.064 -1.023 . . . . 0.0 109.523 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.474 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 97' ' ' ILE . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.689 HG12 ' HB1' ' A' ' 46' ' ' ALA . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 71' ' ' LEU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.416 HH22 ' HA ' ' A' ' 62' ' ' ALA . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' ILE . 19.9 mm-40 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 87' ' ' GLN . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.725 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 97' ' ' ILE . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' OH ' ' A' ' 33' ' ' TYR . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' C ' HD23 ' A' ' 15' ' ' LEU . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 21' ' ' VAL . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 88' ' ' ILE . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.51 -52.46 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.588 ' OH ' HG22 ' A' ' 101' ' ' VAL . 9.5 m-85 -106.04 6.38 31.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.82 -1.175 . . . . 0.0 110.225 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 2.9 p-10 -56.84 -98.72 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.629 -1.294 . . . . 0.0 110.04 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 19.7 mm 44.71 59.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 61.58 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.347 -0.846 . . . . 0.0 109.317 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.45 8.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' OD2' ' OG1' ' A' ' 47' ' ' THR . 33.9 m-20 -70.94 -73.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 110.272 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.4 p -94.15 -8.59 39.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.114 -0.991 . . . . 0.0 110.234 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.23 19.62 79.69 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.97 72.77 1.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.3 t -143.84 11.49 1.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.239 -1.153 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.99 55.09 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.284 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 p -148.55 21.28 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 110.081 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.13 163.06 37.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.953 -1.092 . . . . 0.0 109.402 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.419 ' OG1' ' OD2' ' A' ' 38' ' ' ASP . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.722 HG13 HD11 ' A' ' 97' ' ' ILE . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.737 HG23 ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HB2' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.407 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' LEU . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.488 HH11 ' HB2' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 88' ' ' ILE . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 23' ' ' LEU . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.533 ' SD ' HD21 ' A' ' 23' ' ' LEU . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.737 ' CD1' HG23 ' A' ' 60' ' ' VAL . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.669 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.588 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.568 ' S2 ' ' SD ' ' A' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.434 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.434 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 24' ' ' MET . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 15' ' ' LEU . 67.9 mt -114.49 -26.72 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.868 ' O ' ' N ' ' A' ' 35' ' ' ILE . 1.9 t80 -73.04 3.09 5.84 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.096 -1.002 . . . . 0.0 112.796 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.65 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 CA-C-N 120.318 1.417 . . . . 0.0 111.804 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.868 ' N ' ' O ' ' A' ' 33' ' ' TYR . 16.0 tt -100.83 162.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -43.71 -40.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 47' ' ' THR . . . 61.07 66.88 2.39 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -68.62 -71.87 0.2 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -1.117 . . . . 0.0 110.369 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.1 p -79.84 3.97 18.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.061 -1.024 . . . . 0.0 110.182 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.45 25.24 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.96 26.76 5.93 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.449 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.6 t -98.53 22.26 10.09 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.083 -1.245 . . . . 0.0 109.048 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.29 62.12 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.554 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 19.31 1.26 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.871 . . . . 0.0 109.131 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p -157.1 -169.77 3.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -0.853 . . . . 0.0 109.875 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 37' ' ' GLY . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.596 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.939 HD22 ' CD ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.62 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 84' ' ' LEU . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.539 HG12 ' HB1' ' A' ' 46' ' ' ALA . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 83' ' ' ARG . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.939 ' CD ' HD22 ' A' ' 64' ' ' ASN . 31.5 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 60' ' ' VAL . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.644 ' CE ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 94' ' ' LEU . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.644 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.552 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 3' ' ' VAL . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 HH12 ' A' ' 13' ' ' ARG . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.481 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 24' ' ' MET . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 85' ' ' CYS . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.605 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 15' ' ' LEU . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 15' ' ' LEU . 79.1 mt -115.22 -35.99 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.857 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.83 10.38 1.45 Allowed 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.144 -0.973 . . . . 0.0 111.94 -176.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.1 53.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.909 1.231 . . . . 0.0 111.641 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.857 ' N ' ' O ' ' A' ' 33' ' ' TYR . 36.3 mt -104.58 -83.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 36' ' ' VAL . 10.8 p -172.38 129.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.125 -0.984 . . . . 0.0 109.307 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.08 64.17 4.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.13 -72.22 0.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.189 -1.183 . . . . 0.0 109.837 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.6 p -96.24 -15.07 22.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 0.0 109.539 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.05 15.96 74.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.9 16.55 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -98.62 17.09 19.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.225 -1.162 . . . . 0.0 108.901 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.2 66.46 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.463 -0.773 . . . . 0.0 109.946 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.19 5.81 0.98 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' HG22 ' A' ' 47' ' ' THR . 2.0 p -143.86 -175.52 4.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 0.0 108.897 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.558 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG13 HD11 ' A' ' 97' ' ' ILE . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 94' ' ' LEU . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 78' ' ' LEU . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.419 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 82' ' ' SER . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD23 ' S1 ' ' A' ' 107' ' ' FES . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 23' ' ' LEU . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 60' ' ' VAL . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.4 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.465 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.575 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.674 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.674 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.63 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.548 HD11 HD21 ' A' ' 15' ' ' LEU . 17.5 mt -114.84 -65.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' OH ' HG22 ' A' ' 101' ' ' VAL . 15.7 m-85 -89.95 9.32 28.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.926 -1.109 . . . . 0.0 111.458 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 2.9 p-10 -57.71 -100.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.164 -1.585 . . . . 0.0 110.434 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 17.7 mm 40.88 54.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 63.19 107.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.286 -0.884 . . . . 0.0 109.243 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.84 132.09 10.85 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.03 -72.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.275 . . . . 0.0 109.863 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -98.55 5.67 47.71 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.055 -1.028 . . . . 0.0 110.523 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.78 -4.22 16.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.1 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.1 29.28 4.93 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 50.7 m -98.5 22.46 9.78 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.482 -1.011 . . . . 0.0 108.965 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.34 61.04 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -147.04 18.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 109.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.0 -168.84 2.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.822 -1.174 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.572 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 94' ' ' LEU . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CB ' HD21 ' A' ' 94' ' ' LEU . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.481 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 78' ' ' LEU . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.53 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.572 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 84' ' ' LEU . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' SD ' ' A' ' 90' ' ' MET . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.696 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 21' ' ' VAL . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 17' ' ' VAL . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.604 HD11 HD21 ' A' ' 15' ' ' LEU . 3.7 mt -114.81 -63.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.59 ' OH ' HG22 ' A' ' 101' ' ' VAL . 25.0 m-85 -90.34 8.27 34.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.658 -1.276 . . . . 0.0 111.13 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 35' ' ' ILE . 1.6 p-10 -55.04 -98.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.535 -1.353 . . . . 0.0 109.22 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 34' ' ' ASP . 3.2 tt 33.11 88.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 36' ' ' VAL . 9.2 p 28.46 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.104 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.42 138.94 19.12 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.27 -72.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.609 -0.936 . . . . 0.0 109.728 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.8 p -95.23 -3.02 48.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.464 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.87 60.09 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.65 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.07 25.84 6.28 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 121.232 -1.158 . . . . 0.0 110.326 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -98.01 18.26 16.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -1.154 . . . . 0.0 109.084 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 59.12 58.61 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.075 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t -146.87 18.72 1.27 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.091 -1.006 . . . . 0.0 109.902 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.436 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p -154.04 -168.46 2.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 0.0 109.813 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.555 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG12 HD22 ' A' ' 53' ' ' ASN . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 94' ' ' LEU . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 66' ' ' ARG . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 70' ' ' MET . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 82' ' ' SER . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 60' ' ' VAL . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' NZ ' ' OE1' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 17' ' ' VAL . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 90' ' ' MET . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.401 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt -112.24 -38.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.23 13.69 0.08 Allowed 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.302 -0.874 . . . . 0.0 112.764 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.33 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 120.061 1.3 . . . . 0.0 111.576 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.828 ' N ' ' O ' ' A' ' 33' ' ' TYR . 26.2 mt -105.29 11.45 8.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 47' ' ' THR . 4.4 t 56.09 78.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.654 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.09 108.27 2.42 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -68.0 -65.24 0.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -1.071 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.1 p -66.27 -5.02 9.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.49 6.76 62.88 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 104.71 21.57 9.06 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.8 t -97.94 19.81 13.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.974 -1.309 . . . . 0.0 109.304 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.79 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -0.795 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.45 16.2 1.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.048 . . . . 0.0 109.829 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p -146.78 -168.71 3.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.963 -1.085 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 35' ' ' ILE . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.75 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.676 HG13 HD11 ' A' ' 97' ' ' ILE . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CG ' HG12 ' A' ' 97' ' ' ILE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' LEU . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 60' ' ' VAL . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.676 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 82' ' ' SER . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 82' ' ' SER . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.679 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.676 HH21 ' N ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.676 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.596 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 97' ' ' ILE . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' OE1' HD13 ' A' ' 35' ' ' ILE . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.535 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.485 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.657 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.748 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' ND2' HD22 ' A' ' 15' ' ' LEU . 7.2 m120 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.603 HD11 HD21 ' A' ' 15' ' ' LEU . 4.3 mt -110.78 -61.19 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.736 ' O ' ' N ' ' A' ' 35' ' ' ILE . 35.6 m-85 -82.86 24.71 0.72 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.758 -1.214 . . . . 0.0 112.541 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 27.9 p-10 -47.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.103 1.43 . . . . 0.0 111.023 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.736 ' N ' ' O ' ' A' ' 33' ' ' TYR . 47.5 mm -128.08 157.06 40.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 113.688 -1.597 . . . . 0.0 110.354 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 35' ' ' ILE . 66.2 t -42.62 -32.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 110.508 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 49.43 89.75 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -67.38 -69.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -1.093 . . . . 0.0 110.157 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.1 p -68.4 -0.03 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 109.918 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.85 4.81 59.66 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.24 23.2 8.63 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 9.3 p -98.24 19.89 13.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.697 -0.884 . . . . 0.0 109.537 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.53 60.05 3.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 109.752 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.21 20.31 1.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p -153.47 -175.31 5.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.172 -0.955 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.674 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.715 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 84' ' ' LEU . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 78' ' ' LEU . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' LEU . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 71' ' ' LEU . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.875 ' H ' HD23 ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 HG23 ' A' ' 60' ' ' VAL . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.629 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.556 ' SD ' ' CE2' ' A' ' 33' ' ' TYR . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 HD21 ' A' ' 15' ' ' LEU . 28.6 mt -116.44 -31.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.793 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -63.67 9.32 0.06 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.253 -0.904 . . . . 0.0 112.813 -176.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.06 35.62 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.683 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.793 ' N ' ' O ' ' A' ' 33' ' ' TYR . 10.9 pt -102.1 14.37 5.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.7 t 57.83 97.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.611 -0.681 . . . . 0.0 109.616 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.36 100.7 2.55 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 -68.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -1.144 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.3 p -64.49 -6.57 7.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.46 18.05 76.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 22.48 28.76 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.438 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.5 t -98.29 13.8 30.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.422 -1.046 . . . . 0.0 108.806 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.44 61.56 2.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.476 -0.765 . . . . 0.0 109.806 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.84 10.24 1.04 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.104 -0.998 . . . . 0.0 109.69 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p -137.93 -168.45 2.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.342 -0.849 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' ILE . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 97' ' ' ILE . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.663 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 71' ' ' LEU . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.663 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.438 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.55 ' NE2' HG21 ' A' ' 35' ' ' ILE . 1.4 tt0 -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 3' ' ' VAL . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 11' ' ' THR . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HD2' HD11 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.438 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' HD2' ' A' ' 13' ' ' ARG . 83.9 mt -118.78 -55.08 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 9.38 25.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.3 -0.875 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 36' ' ' VAL . 2.0 p-10 -57.75 -98.19 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.572 -1.33 . . . . 0.0 109.225 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 15.2 mm 61.0 -67.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.272 0.558 . . . . 0.0 109.543 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 34' ' ' ASP . 40.8 t -142.34 -74.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.021 -1.049 . . . . 0.0 108.91 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.12 98.76 0.69 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.78 -72.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 110.461 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.2 p -73.46 -14.72 61.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.677 -1.265 . . . . 0.0 110.018 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.69 22.96 78.15 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.438 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 91.24 19.4 42.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.425 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 3.4 m -95.37 12.75 28.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -1.11 . . . . 0.0 108.859 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.28 2.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.0 109.57 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.64 19.27 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -148.66 177.25 9.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.851 -1.155 . . . . 0.0 109.549 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 97' ' ' ILE . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.605 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 66' ' ' ARG . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 46' ' ' ALA . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 71' ' ' LEU . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.682 ' NE2' HD23 ' A' ' 84' ' ' LEU . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 84' ' ' LEU . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.703 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.498 ' N ' HD12 ' A' ' 97' ' ' ILE . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.494 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 HH12 ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 12' ' ' ARG . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.453 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 21' ' ' VAL . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 ' HB ' HG12 ' A' ' 17' ' ' VAL . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 27' ' ' ALA . 6.8 m120 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 15' ' ' LEU . 70.4 mt -115.99 -60.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 1.7 t80 -87.33 5.34 39.0 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.82 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.4 p-10 -61.5 -91.31 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 109.411 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.468 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 26.2 mt 48.24 -82.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 34' ' ' ASP . 4.4 m -133.37 -166.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.101 -1.0 . . . . 0.0 108.881 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.07 95.63 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -68.22 -71.9 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -1.138 . . . . 0.0 110.972 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.1 p -74.71 2.8 9.14 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.035 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.95 -1.63 30.7 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 25.63 6.3 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.461 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 t -98.55 25.45 6.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -1.172 . . . . 0.0 109.191 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.15 60.62 3.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.75 17.67 1.28 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 4.4 p -150.99 -168.53 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.422 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 97' ' ' ILE . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' HD22 ' A' ' 94' ' ' LEU . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 94' ' ' LEU . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.783 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 78' ' ' LEU . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 71' ' ' LEU . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.783 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG23 HG11 ' A' ' 60' ' ' VAL . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.646 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.453 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 17' ' ' VAL . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 5.3 mt -114.14 -63.09 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' HG22 ' A' ' 101' ' ' VAL . 12.6 m-85 -89.18 8.84 28.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.834 -1.166 . . . . 0.0 111.931 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.8 p-10 -57.37 -100.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.064 -1.647 . . . . 0.0 109.62 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 34' ' ' ASP . 1.6 pt 28.92 -90.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 121.262 0.554 . . . . 0.0 110.352 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 20.5 t -95.01 148.69 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 108.966 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.41 88.79 0.11 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.4 -71.91 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.177 -1.19 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 42' ' ' SER . 5.5 p -86.5 -5.39 59.16 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.116 -0.99 . . . . 0.0 110.228 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.14 6.15 64.0 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.671 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 22.13 8.12 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.505 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 11.7 t -97.83 18.74 15.1 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.115 -1.227 . . . . 0.0 109.114 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.42 57.72 3.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.02 24.0 1.18 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.987 -1.071 . . . . 0.0 109.51 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.69 -168.39 2.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 94' ' ' LEU . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.732 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 1.2 p-10 -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.595 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 78' ' ' LEU . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.677 HH11 HD11 ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.677 HD11 HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 97' ' ' ILE . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.431 ' H ' ' HE3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 59' ' ' LYS . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.461 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.665 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' OH ' ' A' ' 33' ' ' TYR . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.522 HG12 ' CE1' ' A' ' 5' ' ' TYR . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 3' ' ' VAL . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 32' ' ' ILE . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.515 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 15' ' ' LEU . 28.5 mt -115.14 -34.47 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.878 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -73.71 11.31 0.86 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.914 -1.117 . . . . 0.0 112.661 -176.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -49.42 52.21 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 119.891 1.223 . . . . 0.0 111.466 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.878 ' N ' ' O ' ' A' ' 33' ' ' TYR . 70.1 mt -113.09 154.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -65.85 67.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.962 -1.086 . . . . 0.0 109.59 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ILE . . . -57.22 96.43 0.05 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -67.45 -57.41 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -1.096 . . . . 0.0 109.758 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -80.95 -2.44 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.859 -1.151 . . . . 0.0 110.023 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.55 7.4 68.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.14 22.76 10.31 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 32.3 m -98.27 20.52 12.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -1.012 . . . . 0.0 108.919 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.23 62.69 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.947 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.53 8.78 1.03 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.054 . . . . 0.0 109.558 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p -140.24 -168.96 2.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 97' ' ' ILE . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' HB2' HD13 ' A' ' 97' ' ' ILE . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 78' ' ' LEU . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.413 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.494 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 71' ' ' LEU . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 84' ' ' LEU . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 60' ' ' VAL . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.849 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.757 HD12 HG23 ' A' ' 60' ' ' VAL . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.849 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' NE2' HD13 ' A' ' 35' ' ' ILE . 2.1 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.413 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.404 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG21 ' CG2' ' A' ' 17' ' ' VAL . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 11' ' ' THR . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 15' ' ' LEU . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 17' ' ' VAL . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 13' ' ' ARG . 96.8 mt -120.56 -40.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.15 2.05 42.65 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.281 -0.887 . . . . 0.0 111.299 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 36' ' ' VAL . 3.2 p-10 -70.56 -63.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 119.987 -1.696 . . . . 0.0 109.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 34' ' ' ASP . 17.4 tt -25.91 -38.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 34' ' ' ASP . 48.6 t -138.35 119.78 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.136 -0.977 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.47 101.18 0.21 Allowed Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -75.73 -75.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.882 -1.363 . . . . 0.0 111.24 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -86.74 -3.75 59.09 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.875 -1.14 . . . . 0.0 111.147 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.99 13.0 75.77 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.38 -1.39 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 24.27 20.13 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.157 -1.202 . . . . 0.0 110.81 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.6 t -89.69 20.24 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 108.811 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.21 58.69 5.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.7 . . . . 0.0 109.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -150.05 26.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.114 -0.991 . . . . 0.0 110.268 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p -161.47 -166.14 1.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.068 -1.02 . . . . 0.0 110.22 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 97' ' ' ILE . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 94' ' ' LEU . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CB ' HD21 ' A' ' 94' ' ' LEU . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 78' ' ' LEU . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 46' ' ' ALA . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.547 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 71' ' ' LEU . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.586 HG23 HG11 ' A' ' 60' ' ' VAL . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.912 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 56' ' ' PHE . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.912 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 ' HD2' ' A' ' 102' ' ' PRO . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 101' ' ' VAL . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.505 ' NE2' ' H ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.505 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.59 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 15' ' ' LEU . 7.5 mt . . . . . 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 84' ' ' LEU . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 HD13 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.715 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.722 HD21 ' NE2' ' A' ' 87' ' ' GLN . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.666 ' CD2' HD11 ' A' ' 78' ' ' LEU . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.521 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 48' ' ' CYS . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.722 ' NE2' HD21 ' A' ' 64' ' ' ASN . 15.9 mm100 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.511 HG23 HG11 ' A' ' 60' ' ' VAL . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 97' ' ' ILE . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD13 HG23 ' A' ' 60' ' ' VAL . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.599 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.556 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 HG21 ' A' ' 88' ' ' ILE . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 15' ' ' LEU . 5.8 mt . . . . . 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.745 0.783 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.474 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 97' ' ' ILE . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.689 HG12 ' HB1' ' A' ' 46' ' ' ALA . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 71' ' ' LEU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.416 HH22 ' HA ' ' A' ' 62' ' ' ALA . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' ILE . 15.9 mm100 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 87' ' ' GLN . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.725 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 97' ' ' ILE . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' C ' HD23 ' A' ' 15' ' ' LEU . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 21' ' ' VAL . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 88' ' ' ILE . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.465 0.65 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.722 HG13 HD11 ' A' ' 97' ' ' ILE . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.737 HG23 ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HB2' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.407 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' LEU . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.488 HH11 ' HB2' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 88' ' ' ILE . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 23' ' ' LEU . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.533 ' SD ' HD21 ' A' ' 23' ' ' LEU . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.737 ' CD1' HG23 ' A' ' 60' ' ' VAL . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.669 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.434 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.434 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 24' ' ' MET . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 15' ' ' LEU . 67.9 mt . . . . . 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.046 0.451 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.596 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.687 ' ND2' HE22 ' A' ' 87' ' ' GLN . 0.3 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.62 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 84' ' ' LEU . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.539 HG12 ' HB1' ' A' ' 46' ' ' ALA . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 83' ' ' ARG . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.687 HE22 ' ND2' ' A' ' 64' ' ' ASN . 5.9 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 60' ' ' VAL . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.644 ' CE ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 94' ' ' LEU . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.644 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.552 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 3' ' ' VAL . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 HH12 ' A' ' 13' ' ' ARG . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.481 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.533 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 85' ' ' CYS . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.533 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 15' ' ' LEU . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 15' ' ' LEU . 79.1 mt . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' HG22 ' A' ' 47' ' ' THR . 2.0 p . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.558 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG13 HD11 ' A' ' 97' ' ' ILE . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 94' ' ' LEU . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 78' ' ' LEU . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.419 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 82' ' ' SER . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 23' ' ' LEU . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 60' ' ' VAL . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.4 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.575 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.674 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.674 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.63 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.548 HD11 HD21 ' A' ' 15' ' ' LEU . 17.5 mt . . . . . 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.11 0.481 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.572 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 94' ' ' LEU . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CB ' HD21 ' A' ' 94' ' ' LEU . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.481 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 78' ' ' LEU . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.53 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.572 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 84' ' ' LEU . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' SD ' ' A' ' 90' ' ' MET . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.696 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 21' ' ' VAL . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 17' ' ' VAL . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.604 HD11 HD21 ' A' ' 15' ' ' LEU . 3.7 mt . . . . . 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.436 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.073 0.463 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.555 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG12 HD22 ' A' ' 53' ' ' ASN . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 94' ' ' LEU . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 66' ' ' ARG . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 70' ' ' MET . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 82' ' ' SER . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 60' ' ' VAL . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' NZ ' ' OE1' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 17' ' ' VAL . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 90' ' ' MET . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.486 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p . . . . . 0 N--CA 1.5 2.051 0 CA-C-O 121.35 0.595 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 HG22 ' OXT' ' A' ' 106' ' ' TRP . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.75 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.676 HG13 HD11 ' A' ' 97' ' ' ILE . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CG ' HG12 ' A' ' 97' ' ' ILE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' LEU . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 60' ' ' VAL . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.676 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 82' ' ' SER . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 82' ' ' SER . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.679 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.676 HH21 ' N ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.676 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.596 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 97' ' ' ILE . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.535 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.485 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.657 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.748 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m-80 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.603 HD11 HD21 ' A' ' 15' ' ' LEU . 4.3 mt . . . . . 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.528 0.68 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.674 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.715 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 84' ' ' LEU . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 78' ' ' LEU . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' LEU . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 71' ' ' LEU . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.875 ' H ' HD23 ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 HG23 ' A' ' 60' ' ' VAL . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.629 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 HD21 ' A' ' 15' ' ' LEU . 28.6 mt . . . . . 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.498 0.666 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 97' ' ' ILE . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.663 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 71' ' ' LEU . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.663 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.438 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 105' ' ' GLN . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 3' ' ' VAL . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 11' ' ' THR . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HD2' HD11 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 30.6 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' HD2' ' A' ' 13' ' ' ARG . 83.9 mt . . . . . 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.46 0.647 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 97' ' ' ILE . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.605 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 66' ' ' ARG . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 46' ' ' ALA . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 71' ' ' LEU . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.682 ' NE2' HD23 ' A' ' 84' ' ' LEU . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 84' ' ' LEU . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.703 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.498 ' N ' HD12 ' A' ' 97' ' ' ILE . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 HH12 ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 12' ' ' ARG . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.453 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 21' ' ' VAL . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 ' HB ' HG12 ' A' ' 17' ' ' VAL . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 30' ' ' ASN . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 27' ' ' ALA . 5.4 m-80 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 15' ' ' LEU . 70.4 mt . . . . . 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.357 0.598 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 97' ' ' ILE . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' HD22 ' A' ' 94' ' ' LEU . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 94' ' ' LEU . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.783 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 78' ' ' LEU . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 71' ' ' LEU . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.783 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG23 HG11 ' A' ' 60' ' ' VAL . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.646 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.453 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 17' ' ' VAL . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 5.3 mt . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 94' ' ' LEU . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.732 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.76 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 78' ' ' LEU . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.677 HH11 HD11 ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.537 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.677 HD11 HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 97' ' ' ILE . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.431 ' H ' ' HE3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 59' ' ' LYS . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.461 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.665 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.522 HG12 ' CE1' ' A' ' 5' ' ' TYR . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 3' ' ' VAL . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 32' ' ' ILE . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.515 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 15' ' ' LEU . 28.5 mt . . . . . 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 97' ' ' ILE . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.51 ' HB2' HD13 ' A' ' 97' ' ' ILE . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 78' ' ' LEU . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.413 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.494 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 71' ' ' LEU . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 84' ' ' LEU . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.532 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 60' ' ' VAL . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.849 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.757 HD12 HG23 ' A' ' 60' ' ' VAL . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.849 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.413 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG21 ' CG2' ' A' ' 17' ' ' VAL . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 11' ' ' THR . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 15' ' ' LEU . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 17' ' ' VAL . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 13' ' ' ARG . 96.8 mt . . . . . 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.591 0.71 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 97' ' ' ILE . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 94' ' ' LEU . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CB ' HD21 ' A' ' 94' ' ' LEU . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 78' ' ' LEU . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 46' ' ' ALA . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.547 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 71' ' ' LEU . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.586 HG23 HG11 ' A' ' 60' ' ' VAL . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.912 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 56' ' ' PHE . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.912 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 ' HD2' ' A' ' 102' ' ' PRO . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 101' ' ' VAL . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.505 ' NE2' ' H ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.505 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 119.52 24.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' CE2' ' A' ' 5' ' ' TYR . 2.1 t -119.93 125.4 74.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.951 -1.093 . . . . 0.0 109.027 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.95 129.96 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 122.189 0.995 . . . . 0.0 109.748 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 54.9 m-85 -107.55 119.18 38.71 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.55 109.24 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 78.8 p -72.63 -176.28 1.91 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.041 0.924 . . . . 0.0 110.496 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.16 -45.2 18.54 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 7' ' ' SER . 21.7 p30 -65.84 -4.31 6.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.658 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.94 -12.89 62.4 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.18 127.29 31.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.002 -1.293 . . . . 0.0 109.242 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.86 136.46 42.64 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.358 0.599 . . . . 0.0 110.451 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.583 ' HB2' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.13 121.14 28.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.59 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.0 mt-10 -106.75 130.55 54.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.44 -0.788 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -124.9 171.97 9.75 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.916 -1.115 . . . . 0.0 109.778 178.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -108.14 117.64 34.67 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.1 t -112.2 120.93 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.94 167.81 19.31 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.925 0.869 . . . . 0.0 111.451 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.93 138.98 58.7 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.416 1.103 . . . . 0.0 110.09 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.53 -3.76 83.98 Favored Glycine 0 C--N 1.289 -2.031 0 C-N-CA 120.291 -0.957 . . . . 0.0 110.982 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.9 t -94.04 147.56 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.578 1.689 . . . . 0.0 109.44 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -91.61 143.31 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.884 -1.135 . . . . 0.0 109.244 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' C ' ' SG ' ' A' ' 85' ' ' CYS . 28.8 mt -50.64 -23.14 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.859 -1.151 . . . . 0.0 108.541 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.595 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 5.0 ttp -73.0 -41.98 63.72 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -60.14 -55.1 38.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.396 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.58 -27.8 69.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.855 -1.153 . . . . 0.0 111.263 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.48 66.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.942 -1.099 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.18 -19.24 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.132 -0.98 . . . . 0.0 109.705 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.17 -23.49 20.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.222 -0.924 . . . . 0.0 111.138 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -107.43 14.61 25.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.19 32.71 65.32 Favored Glycine 0 N--CA 1.502 3.038 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.146 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 15' ' ' LEU . 7.5 mt -108.83 -29.61 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 118.741 1.27 . . . . 0.0 110.802 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -70.36 5.48 1.73 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.146 -0.972 . . . . 0.0 113.548 -177.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.28 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 120.505 1.502 . . . . 0.0 111.725 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.796 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.8 pt -99.8 10.54 7.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.9 t 54.62 62.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.47 111.57 1.08 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.02 -64.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.266 -1.137 . . . . 0.0 109.616 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.5 p -64.24 -2.87 2.35 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.79 -1.194 . . . . 0.0 109.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.93 13.78 75.75 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.785 -1.197 . . . . 0.0 110.227 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.77 20.27 26.95 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -98.18 15.91 22.95 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.236 -1.155 . . . . 0.0 108.152 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.19 65.14 1.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.644 -0.66 . . . . 0.0 109.46 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.73 18.45 1.29 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.288 -0.882 . . . . 0.0 109.306 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.6 p -148.08 -169.97 3.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.067 -1.021 . . . . 0.0 109.074 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.67 23.57 4.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 m -75.2 -22.64 57.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.697 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 84' ' ' LEU . 7.2 p -87.24 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.316 -0.865 . . . . 0.0 110.051 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.542 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 36.4 t60 -68.45 109.72 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.378 -0.826 . . . . 0.0 109.865 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -138.24 171.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.873 -1.142 . . . . 0.0 108.051 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 94.0 m-85 -119.56 112.98 20.02 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.334 1.064 . . . . 0.0 109.362 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.1 t -89.68 129.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.005 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.3 t-20 -49.44 121.98 5.68 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.532 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 8.0 pt-20 -47.48 -1.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 111.67 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.01 -13.75 40.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.513 -1.367 . . . . 0.0 111.247 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.2 m-85 -118.28 -7.23 10.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.262 -1.524 . . . . 0.0 108.236 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 p -69.25 -40.28 77.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.738 -0.601 . . . . 0.0 110.534 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.84 14.2 12.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -121.17 -46.22 2.32 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 HD13 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -73.04 150.65 90.26 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' ALA . 5.1 Cg_exo -42.06 110.59 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.818 2.345 . . . . 0.0 113.967 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -36.06 127.78 0.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.58 1.181 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.715 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -49.53 144.67 5.56 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.901 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.722 HD21 ' NE2' ' A' ' 87' ' ' GLN . 1.6 p30 -84.27 157.55 21.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -55.43 -14.38 1.93 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.805 -0.559 . . . . 0.0 110.867 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -75.11 -33.6 61.61 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.237 -1.54 . . . . 0.0 108.233 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.15 -42.41 65.98 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.52 -0.738 . . . . 0.0 109.948 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.61 -42.83 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.063 -1.023 . . . . 0.0 109.482 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.06 61.64 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 40.9 mtm -79.59 -25.31 41.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.924 -1.339 . . . . 0.0 107.871 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.666 ' CD2' HD11 ' A' ' 78' ' ' LEU . 5.4 mt -68.43 -28.56 67.17 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -80.83 -7.73 59.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.334 -1.479 . . . . 0.0 108.5 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 10.49 38.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.672 -0.643 . . . . 0.0 110.448 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -74.23 161.62 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.684 -1.26 . . . . 0.0 110.895 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.9 m -91.03 -21.16 21.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.537 -0.727 . . . . 0.0 111.001 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.97 -176.09 3.15 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.539 -1.35 . . . . 0.0 110.078 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.521 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.73 129.55 37.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.165 -0.96 . . . . 0.0 110.975 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.1 tp -79.89 159.74 26.28 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.661 -1.274 . . . . 0.0 109.856 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.8 mmtp -122.75 159.1 54.83 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.475 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.31 -38.86 94.38 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.612 1.541 . . . . 0.0 109.479 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -110.21 30.8 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.655 . . . . 0.0 110.406 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -69.57 145.69 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.812 -1.18 . . . . 0.0 108.58 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 12.4 mmt180 -143.3 175.84 9.6 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.606 0.717 . . . . 0.0 110.556 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 48' ' ' CYS . 8.7 mp -113.56 174.76 5.76 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 24' ' ' MET . 40.9 t -107.05 -17.44 14.17 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.828 -1.17 . . . . 0.0 112.421 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.3 p -94.27 10.32 34.55 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.627 -1.296 . . . . 0.0 111.787 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.722 ' NE2' HD21 ' A' ' 64' ' ' ASN . 15.9 mm100 -129.4 11.76 5.88 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.953 -1.092 . . . . 0.0 109.927 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.511 HG23 HG11 ' A' ' 60' ' ' VAL . 23.9 mt -116.17 128.94 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-O 121.731 0.777 . . . . 0.0 111.437 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.04 120.41 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 CA-C-O 121.059 0.457 . . . . 0.0 110.46 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 97' ' ' ILE . 3.8 tpt -79.31 157.62 27.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 110.105 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -149.82 148.97 26.82 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.53 -42.85 61.07 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.869 1.713 . . . . 0.0 111.698 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -55.14 -37.49 67.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.542 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD13 HG23 ' A' ' 60' ' ' VAL . 9.2 mt -88.41 21.85 2.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.142 -0.974 . . . . 0.0 110.212 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -56.6 137.73 53.33 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.063 -1.023 . . . . 0.0 110.146 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.85 0.95 28.8 Favored Glycine 0 N--CA 1.508 3.458 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.599 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -56.87 129.08 18.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 O-C-N 121.956 -0.732 . . . . 0.0 111.003 -176.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.556 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.34 117.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.383 -0.823 . . . . 0.0 109.829 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.74 127.89 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.201 -0.937 . . . . 0.0 109.31 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.77 121.38 43.91 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.653 0.74 . . . . 0.0 109.438 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.4 t -107.61 130.78 22.34 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.12 -172.61 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.548 2.165 . . . . 0.0 114.09 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.67 -16.83 25.05 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -119.23 105.81 11.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.636 HE22 HG22 ' A' ' 35' ' ' ILE . 2.3 pt20 -118.38 -17.17 9.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 0.0 108.562 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.472 -179.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.485 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -84.08 122.39 28.74 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.64 123.26 70.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.782 -1.199 . . . . 0.0 108.88 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.2 t -111.78 132.83 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 122.209 1.004 . . . . 0.0 109.946 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -109.53 116.84 32.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.17 113.68 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.2 p -75.95 179.22 5.7 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.38 1.086 . . . . 0.0 111.761 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.85 -44.75 26.33 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.23 -5.88 8.12 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.566 -0.709 . . . . 0.0 109.192 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.29 -14.96 61.92 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.925 -1.11 . . . . 0.0 110.759 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.68 130.22 42.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.862 -1.375 . . . . 0.0 109.309 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -103.29 135.48 44.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.712 -0.618 . . . . 0.0 110.771 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -131.92 128.53 38.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.6 mp0 -116.92 138.42 51.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.341 -0.849 . . . . 0.0 110.962 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -126.83 173.39 9.6 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 122.244 1.021 . . . . 0.0 110.082 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.29 113.88 27.32 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.8 t -111.77 124.4 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.08 30.9 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.249 1.023 . . . . 0.0 111.649 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -56.68 140.19 47.96 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.058 0.933 . . . . 0.0 109.929 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.93 1.78 85.43 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.324 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.692 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.2 t -93.68 152.65 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.414 1.607 . . . . 0.0 109.153 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 135.97 33.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 HG21 ' A' ' 88' ' ' ILE . 48.0 mt -48.61 -34.14 11.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.705 -1.247 . . . . 0.0 108.844 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 8.1 tpt -66.65 -38.26 86.5 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -57.91 -57.32 13.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 108.965 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.66 -25.69 67.46 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.432 -1.417 . . . . 0.0 110.815 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.24 -62.81 1.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.096 . . . . 0.0 110.06 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.95 -19.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.549 -0.719 . . . . 0.0 109.761 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -17.59 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 0.0 109.927 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -111.88 12.56 20.86 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.55 45.84 65.29 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.342 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 15' ' ' LEU . 5.8 mt -115.77 -63.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 CA-C-N 119.766 1.783 . . . . 0.0 113.8 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' OH ' HG22 ' A' ' 101' ' ' VAL . 11.6 m-85 -89.14 8.36 30.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.746 -1.221 . . . . 0.0 110.841 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ILE . 1.6 p-10 -59.24 -99.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.613 -1.304 . . . . 0.0 109.194 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' ASP . 1.2 tp 31.52 85.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.985 0.898 . . . . 0.0 109.914 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.5 t 52.9 98.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.827 -1.171 . . . . 0.0 109.519 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.03 123.45 7.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -72.61 0.17 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -1.161 . . . . 0.0 110.565 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.9 p -104.41 1.94 30.64 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.49 -4.16 21.56 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.579 -1.296 . . . . 0.0 109.939 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.59 31.59 3.92 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.379 -1.071 . . . . 0.0 110.479 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.7 t -98.82 20.72 12.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.9 . . . . 0.0 108.646 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.97 62.72 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.607 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -146.95 4.72 0.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.3 p -142.46 -168.51 2.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.064 -1.023 . . . . 0.0 109.523 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -134.75 11.07 3.68 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -61.91 -22.94 66.0 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.474 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.1 p -82.82 36.97 0.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.838 . . . . 0.0 110.235 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.2 t60 -70.72 113.48 7.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -141.34 174.18 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 108.73 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 77.1 m-85 -121.39 110.31 15.93 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.126 0.965 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 97' ' ' ILE . 73.8 t -88.65 133.13 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.599 ' O ' ' N ' ' A' ' 55' ' ' ALA . 2.5 m-20 -52.67 121.57 7.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.295 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.99 0.93 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.751 -0.593 . . . . 0.0 111.544 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.408 -1.432 . . . . 0.0 111.261 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.52 -8.24 11.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.368 -1.458 . . . . 0.0 108.137 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.6 p -70.64 -40.31 73.16 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.141 0.496 . . . . 0.0 110.641 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -82.58 -5.07 58.57 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.55 -1.344 . . . . 0.0 109.805 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 7.3 mttm -102.85 -41.72 6.08 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -72.41 159.63 84.88 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.2 Cg_endo -57.32 115.75 2.73 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.974 1.782 . . . . 0.0 114.088 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -37.23 130.6 0.88 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.429 1.109 . . . . 0.0 110.888 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.27 141.22 47.47 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.183 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 4.5 p30 -83.8 162.87 20.46 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.321 1.058 . . . . 0.0 110.37 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -54.53 -15.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.073 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -73.45 -38.53 65.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.457 -1.402 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' OE2' ' OD1' ' A' ' 64' ' ' ASN . 29.0 mt-10 -75.88 -41.47 52.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.27 -33.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.59 -31.75 35.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.0 mtm -80.06 -34.9 37.77 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.647 -1.502 . . . . 0.0 107.524 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD22 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -60.17 -29.98 69.04 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -80.59 -9.72 59.77 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.898 -1.126 . . . . 0.0 108.278 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.39 10.28 41.44 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.613 -0.679 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.689 HG12 ' HB1' ' A' ' 46' ' ' ALA . 20.2 m -77.86 169.57 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.367 -1.458 . . . . 0.0 109.561 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.4 m -93.91 -17.51 22.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 111.543 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.29 -176.45 3.22 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.582 -1.324 . . . . 0.0 110.167 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -77.31 131.45 38.13 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.488 -0.758 . . . . 0.0 111.266 -177.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 71' ' ' LEU . 5.2 tp -82.49 148.8 27.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.669 -1.269 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -110.71 158.2 36.26 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.478 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.79 -34.97 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.71 1.607 . . . . 0.0 109.694 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.468 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -112.56 29.65 7.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -66.02 145.96 55.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.891 -1.131 . . . . 0.0 108.627 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.416 HH22 ' HA ' ' A' ' 62' ' ' ALA . 5.7 mmt180 -143.75 170.29 16.15 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.949 0.88 . . . . 0.0 110.172 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.52 174.99 5.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 24' ' ' MET . 42.1 t -107.15 -14.53 14.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.537 -0.727 . . . . 0.0 112.126 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 29.4 p -98.17 -15.36 19.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.764 -1.21 . . . . 0.0 111.868 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' ILE . 15.9 mm100 -108.63 9.63 27.17 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 87' ' ' GLN . 1.4 mp -101.78 118.82 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.95 120.55 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.407 -0.808 . . . . 0.0 110.053 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.2 tpt -74.59 155.07 38.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 110.441 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.41 148.99 20.49 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.72 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.05 1.833 . . . . 0.0 112.494 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -32.2 68.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 60' ' ' VAL . 11.5 mt -89.56 11.77 18.63 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.582 0.706 . . . . 0.0 109.744 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 30.0 p-10 -56.17 138.56 49.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.728 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.57 -0.73 36.85 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.51 132.35 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.995 . . . . 0.0 112.287 -176.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.725 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.2 t -105.17 115.41 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.496 HG22 HD12 ' A' ' 97' ' ' ILE . 2.2 t -103.68 125.34 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.16 120.43 40.21 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' OH ' ' A' ' 33' ' ' TYR . 4.3 t -105.67 129.43 24.69 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.776 -0.578 . . . . 0.0 109.848 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 97.7 Cg_endo -83.41 -173.6 1.69 Allowed 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.142 1.895 . . . . 0.0 113.366 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.9 -14.88 28.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -119.66 108.38 14.39 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 3.8 mp0 -115.23 -14.68 11.69 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.943 -1.098 . . . . 0.0 108.727 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.404 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -81.85 119.96 24.57 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -117.68 122.92 70.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.692 -1.255 . . . . 0.0 108.625 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.1 t -113.74 134.88 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.959 0.885 . . . . 0.0 109.538 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.05 120.79 42.55 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -100.78 114.08 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 p -78.22 -177.48 5.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.129 0.966 . . . . 0.0 111.172 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.82 -45.13 21.52 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 1.3 p-10 -65.27 -8.27 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -11.82 61.49 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.924 -1.11 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.6 134.83 43.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.816 -1.402 . . . . 0.0 109.814 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -111.58 139.85 46.67 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.396 0.617 . . . . 0.0 112.116 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -121.41 116.4 24.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' C ' HD23 ' A' ' 15' ' ' LEU . 13.1 mt-10 -100.21 123.99 45.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 108.913 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -118.76 164.72 14.96 Favored 'General case' 0 N--CA 1.508 2.455 0 CA-C-O 122.059 0.933 . . . . 0.0 109.644 178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -103.65 114.85 29.43 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 104.065 -2.568 . . . . 0.0 104.065 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 21' ' ' VAL . 17.9 t -113.33 125.29 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.95 -1.094 . . . . 0.0 108.643 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.32 30.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.104 0.954 . . . . 0.0 111.268 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -61.52 142.08 57.3 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.081 0.943 . . . . 0.0 109.793 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.67 88.54 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.557 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.5 t -96.51 149.37 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 119.793 1.796 . . . . 0.0 109.441 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 p -85.57 139.9 31.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.552 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 88' ' ' ILE . 33.5 mt -50.01 -37.37 32.53 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 108.866 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.603 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 21.0 ttt -66.28 -37.21 84.91 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.636 -0.665 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.54 -54.76 43.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 108.789 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -65.63 -25.43 67.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 110.544 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -45.31 79.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.894 -1.129 . . . . 0.0 109.684 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.06 -21.5 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -19.31 30.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.778 . . . . 0.0 109.39 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -108.86 16.11 22.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.74 56.4 23.99 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.517 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.51 -52.46 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.031 -1.276 . . . . 0.0 112.318 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.588 ' OH ' HG22 ' A' ' 101' ' ' VAL . 9.5 m-85 -106.04 6.38 31.11 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.82 -1.175 . . . . 0.0 110.225 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 2.9 p-10 -56.84 -98.72 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.629 -1.294 . . . . 0.0 110.04 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 19.7 mm 44.71 59.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 61.58 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.347 -0.846 . . . . 0.0 109.317 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.45 8.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' OD2' ' OG1' ' A' ' 47' ' ' THR . 33.9 m-20 -70.94 -73.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 110.272 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.4 p -94.15 -8.59 39.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.114 -0.991 . . . . 0.0 110.234 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.23 19.62 79.69 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.97 72.77 1.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.3 t -143.84 11.49 1.62 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.239 -1.153 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.99 55.09 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.284 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 p -148.55 21.28 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 110.081 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.13 163.06 37.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.953 -1.092 . . . . 0.0 109.402 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.84 10.12 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.423 -0.798 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.419 ' OG1' ' OD2' ' A' ' 38' ' ' ASP . 6.0 m -58.26 -27.54 64.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.311 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 2.3 p -90.99 39.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.547 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 7.8 t60 -75.73 107.99 8.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.139 -0.976 . . . . 0.0 108.852 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -145.53 174.44 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.625 -1.297 . . . . 0.0 108.905 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.0 m-85 -122.81 115.06 21.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.957 0.884 . . . . 0.0 109.353 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.722 HG13 HD11 ' A' ' 97' ' ' ILE . 84.0 t -90.3 133.48 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.346 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 55' ' ' ALA . 6.0 t30 -52.75 120.92 6.29 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.174 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 1.6 pm0 -47.2 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.479 -0.763 . . . . 0.0 111.886 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.85 -15.7 38.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.459 -1.401 . . . . 0.0 111.27 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.39 -7.54 11.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.034 -1.666 . . . . 0.0 108.163 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.1 p -69.52 -40.74 76.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.896 -0.503 . . . . 0.0 110.753 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -85.86 -0.78 56.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.113 -0.992 . . . . 0.0 109.993 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.44 -41.76 5.21 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.737 HG23 ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -76.74 161.69 73.11 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.0 Cg_endo -58.15 115.12 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.715 1.61 . . . . 0.0 113.356 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.87 143.99 1.94 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.66 1.219 . . . . 0.0 110.674 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HB2' HH11 ' A' ' 83' ' ' ARG . . . -69.47 131.29 44.5 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.082 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' OE2' ' A' ' 67' ' ' GLU . 21.6 p30 -73.71 172.55 11.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.056 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.75 -11.45 36.52 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.772 -0.58 . . . . 0.0 112.379 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' O ' ' CE ' ' A' ' 70' ' ' MET . 54.8 mtp180 -73.02 -40.83 64.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.202 -1.561 . . . . 0.0 109.508 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 46.3 mp0 -73.64 -36.22 65.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 110.369 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.4 mm -50.6 -35.45 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 108.712 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.35 -30.84 56.24 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.519 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.512 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 2.6 mpp? -83.31 -33.48 25.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.585 -1.538 . . . . 0.0 107.713 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.407 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.7 mt -61.85 -33.21 73.77 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -74.44 -1.26 20.34 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.787 -1.196 . . . . 0.0 108.292 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 14.1 21.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.89 -0.506 . . . . 0.0 111.325 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.38 165.4 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.623 -1.298 . . . . 0.0 111.493 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -31.4 27.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.872 -0.517 . . . . 0.0 111.347 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -99.69 -175.86 3.1 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.425 -1.422 . . . . 0.0 110.491 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.8 tt0 -66.05 124.23 22.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.466 -0.771 . . . . 0.0 110.973 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 71' ' ' LEU . 9.6 tp -81.64 140.14 34.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.066 -1.646 . . . . 0.0 110.097 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mmmm -103.1 155.6 36.42 Favored Pre-proline 0 C--N 1.289 -2.06 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.148 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.7 -28.64 76.66 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 120.918 1.078 . . . . 0.0 109.524 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -106.38 22.65 15.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.759 -0.588 . . . . 0.0 110.088 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 57.8 m -59.68 143.24 51.24 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.02 -1.675 . . . . 0.0 108.635 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.488 HH11 ' HB2' ' A' ' 63' ' ' ALA . 5.0 mmt180 -136.43 169.25 17.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.347 -0.845 . . . . 0.0 110.645 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 88' ' ' ILE . 34.1 mt -112.63 123.28 49.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 24' ' ' MET . 34.6 t -61.54 2.13 0.19 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.2 p -105.51 -32.31 8.57 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.254 -1.529 . . . . 0.0 111.305 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' O ' ' OE1' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -92.58 9.81 33.08 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.742 -1.224 . . . . 0.0 110.107 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 23' ' ' LEU . 1.1 mp -102.91 117.26 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.405 -0.81 . . . . 0.0 108.844 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.18 123.65 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 O-C-N 121.462 -0.774 . . . . 0.0 111.707 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.533 ' SD ' HD21 ' A' ' 23' ' ' LEU . 5.3 tpt -77.18 154.23 33.33 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.891 -1.131 . . . . 0.0 110.972 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -153.42 149.89 22.37 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.64 -43.44 57.69 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.945 1.763 . . . . 0.0 112.447 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.06 -34.82 68.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.146 . . . . 0.0 108.894 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.737 ' CD1' HG23 ' A' ' 60' ' ' VAL . 24.0 mt -87.4 12.88 11.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.761 -0.587 . . . . 0.0 110.457 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 36.2 p-10 -56.29 137.59 52.06 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.438 -0.788 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.51 0.46 32.75 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -56.59 132.57 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.534 -0.98 . . . . 0.0 112.358 -175.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.669 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.0 t -108.23 119.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.669 -0.645 . . . . 0.0 109.782 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.26 127.5 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.234 -0.917 . . . . 0.0 109.489 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.89 121.82 43.28 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.715 -0.615 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.588 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.1 t -107.07 133.13 20.43 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.845 -0.534 . . . . 0.0 109.948 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.53 -176.41 3.07 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.673 2.249 . . . . 0.0 113.841 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 9.2 p-10 -82.22 -18.92 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.73 115.56 20.26 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 106' ' ' TRP . 13.9 pt20 -120.53 3.13 10.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.966 -1.084 . . . . 0.0 109.47 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CB ' ' O ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.568 ' S2 ' ' SD ' ' A' ' 24' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.0 mmtt -82.49 120.31 25.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 2.3 t -118.76 124.22 72.8 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 O-C-N 120.954 -1.091 . . . . 0.0 108.786 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.32 128.76 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 122.141 0.972 . . . . 0.0 109.885 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CE2' ' CG1' ' A' ' 3' ' ' VAL . 62.8 m-85 -105.64 118.37 36.4 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.92 108.37 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -75.4 -174.98 2.6 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.997 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.03 -45.73 17.84 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -64.15 -7.44 9.0 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.179 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.11 -11.41 65.71 Favored Glycine 0 N--CA 1.503 3.122 0 O-C-N 120.918 -1.114 . . . . 0.0 111.204 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.434 ' CG2' HH11 ' A' ' 13' ' ' ARG . 0.4 OUTLIER -67.34 131.26 45.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.026 -1.279 . . . . 0.0 109.991 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -99.0 128.74 45.2 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.333 -0.855 . . . . 0.0 111.211 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.434 HH11 ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -116.86 110.24 18.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.0 mt-10 -103.86 127.97 51.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -125.07 173.95 8.36 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 122.738 1.256 . . . . 0.0 110.155 178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.89 116.4 31.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 21' ' ' VAL . 6.3 t -112.7 123.15 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 164.52 23.62 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.949 0.88 . . . . 0.0 111.483 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.09 138.9 57.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.234 1.016 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.51 -1.61 71.0 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.5 t -90.61 148.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 119.708 1.754 . . . . 0.0 108.481 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 24' ' ' MET . 1.4 p -93.54 142.86 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.18 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.7 mt -50.51 -13.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.441 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 3.6 ptt? -83.03 -38.93 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 108.957 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' N ' ' CG ' ' A' ' 24' ' ' MET . 2.5 mm100 -60.22 -56.94 15.4 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.624 -0.673 . . . . 0.0 109.246 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.22 -28.37 69.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.817 -1.177 . . . . 0.0 110.813 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.17 -52.65 53.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.348 -1.47 . . . . 0.0 110.16 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.86 -21.05 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.127 -0.983 . . . . 0.0 110.207 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -22.5 18.2 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 111.105 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -100.75 13.56 34.51 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.013 -1.055 . . . . 0.0 109.122 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.67 32.01 67.46 Favored Glycine 0 N--CA 1.5 2.913 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.019 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 15' ' ' LEU . 67.9 mt -114.49 -26.72 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.429 -1.042 . . . . 0.0 111.579 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.868 ' O ' ' N ' ' A' ' 35' ' ' ILE . 1.9 t80 -73.04 3.09 5.84 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.096 -1.002 . . . . 0.0 112.796 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.65 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 CA-C-N 120.318 1.417 . . . . 0.0 111.804 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.868 ' N ' ' O ' ' A' ' 33' ' ' TYR . 16.0 tt -100.83 162.09 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -43.71 -40.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 47' ' ' THR . . . 61.07 66.88 2.39 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 47' ' ' THR . 1.0 OUTLIER -68.62 -71.87 0.2 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -1.117 . . . . 0.0 110.369 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.1 p -79.84 3.97 18.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.061 -1.024 . . . . 0.0 110.182 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.45 25.24 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.96 26.76 5.93 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.449 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.6 t -98.53 22.26 10.09 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.083 -1.245 . . . . 0.0 109.048 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.29 62.12 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.554 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 19.31 1.26 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.871 . . . . 0.0 109.131 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.5 p -157.1 -169.77 3.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -0.853 . . . . 0.0 109.875 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -124.75 7.75 8.16 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 37' ' ' GLY . 52.5 m -54.21 -35.01 61.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.855 -0.528 . . . . 0.0 110.413 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.9 p -84.45 37.64 0.64 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.018 -1.051 . . . . 0.0 110.574 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.558 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.3 t60 -66.22 108.36 2.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.1 175.14 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.886 -1.134 . . . . 0.0 109.012 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.596 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 49.0 m-85 -120.95 115.34 23.0 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 66.7 t -87.77 132.95 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -50.23 121.48 5.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.954 -1.091 . . . . 0.0 108.204 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -47.05 -4.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.29 -0.881 . . . . 0.0 111.286 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -86.11 -15.36 41.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 111.83 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 29.1 m-85 -115.1 -6.45 12.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.366 -1.459 . . . . 0.0 108.785 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.9 p -72.43 -40.62 66.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.422 -0.799 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -82.96 4.27 26.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 8.6 mttp -111.08 -45.19 3.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.967 0.889 . . . . 0.0 109.312 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -75.43 151.91 85.47 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.81 115.51 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.996 2.464 . . . . 0.0 114.311 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.83 137.01 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.617 1.198 . . . . 0.0 110.638 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -64.74 146.8 54.27 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.564 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.687 ' ND2' HE22 ' A' ' 87' ' ' GLN . 0.3 OUTLIER -84.47 160.3 20.58 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.645 0.736 . . . . 0.0 110.222 -178.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -12.32 13.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.814 -0.554 . . . . 0.0 111.858 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -68.78 -34.51 75.67 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.271 -1.518 . . . . 0.0 108.055 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.62 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 57.4 mt-10 -75.44 -40.38 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.759 -0.588 . . . . 0.0 110.835 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -52.35 -35.26 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.82 -1.175 . . . . 0.0 109.281 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.12 -30.67 50.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 15.8 mtm -80.36 -33.24 37.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.75 -1.441 . . . . 0.0 108.369 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 84' ' ' LEU . 53.4 mt -60.06 -29.08 68.31 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -77.37 -6.06 51.95 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.956 -1.09 . . . . 0.0 108.495 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 11.18 26.52 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.825 -0.547 . . . . 0.0 110.661 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.539 HG12 ' HB1' ' A' ' 46' ' ' ALA . 25.1 m -77.44 164.75 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.505 -1.372 . . . . 0.0 110.838 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.48 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 9.9 m -89.27 -28.25 20.03 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.784 -0.573 . . . . 0.0 111.898 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.51 -176.71 3.58 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.153 -1.592 . . . . 0.0 110.565 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.596 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -73.25 130.35 40.02 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.132 -0.98 . . . . 0.0 111.659 -177.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.6 tp -80.13 149.67 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 123.273 1.511 . . . . 0.0 111.34 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -110.49 155.14 42.57 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 113.815 -1.538 . . . . 0.0 107.568 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.13 -31.3 90.01 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 120.821 1.014 . . . . 0.0 109.557 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -108.0 28.82 7.86 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -54.26 139.31 36.56 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.018 -1.676 . . . . 0.0 109.38 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 83' ' ' ARG . 2.4 mmt180 -137.74 152.01 48.77 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.687 0.756 . . . . 0.0 110.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -87.93 161.24 17.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.5 t -106.05 6.06 30.81 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.999 -1.063 . . . . 0.0 111.189 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.6 p -111.3 -27.35 8.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.919 -1.113 . . . . 0.0 110.694 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.687 HE22 ' ND2' ' A' ' 64' ' ' ASN . 5.9 tt0 -99.04 17.37 19.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.936 -1.102 . . . . 0.0 110.727 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 60' ' ' VAL . 9.7 mm -107.55 125.54 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 121.449 -0.782 . . . . 0.0 110.085 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.04 120.88 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 121.477 -0.765 . . . . 0.0 110.319 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.644 ' CE ' HG21 ' A' ' 97' ' ' ILE . 2.1 tpt -78.79 157.71 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.735 0.779 . . . . 0.0 110.414 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -149.82 149.39 27.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.4 -43.41 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.032 1.821 . . . . 0.0 111.507 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -55.96 -36.56 67.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.215 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 94' ' ' LEU . 16.8 mt -89.43 19.57 4.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.077 -1.014 . . . . 0.0 110.85 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.9 p30 -55.72 136.69 50.66 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.87 -0.38 27.26 Favored Glycine 0 N--CA 1.511 3.666 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.644 HG21 ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -55.55 129.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.87 -0.782 . . . . 0.0 111.226 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.2 t -105.71 117.08 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.673 -0.642 . . . . 0.0 109.597 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.62 127.44 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.282 -0.886 . . . . 0.0 108.785 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.33 119.7 39.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.75 131.75 21.47 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.741 -0.599 . . . . 0.0 109.587 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.63 -174.89 2.46 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.788 2.326 . . . . 0.0 114.544 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.51 -19.92 32.47 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.04 117.24 22.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -130.66 -2.61 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 0.0 109.07 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.48 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.609 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 26.1 mmtt -84.78 118.9 24.74 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.854 -1.154 . . . . 0.0 108.166 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.552 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.8 t -114.94 121.45 67.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.84 131.9 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 122.239 1.018 . . . . 0.0 110.303 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 3' ' ' VAL . 79.6 m-85 -108.39 117.75 34.97 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.6 t -99.73 109.57 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 p -75.75 -177.2 3.65 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.225 1.012 . . . . 0.0 111.409 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.49 -46.75 15.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.61 -7.24 4.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.11 61.98 Favored Glycine 0 N--CA 1.501 2.987 0 O-C-N 120.945 -1.097 . . . . 0.0 110.941 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 HH12 ' A' ' 13' ' ' ARG . 0.5 OUTLIER -69.35 131.75 45.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.795 -1.415 . . . . 0.0 110.313 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -103.65 133.26 48.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.964 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.481 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -126.79 120.99 30.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.3 mp0 -109.1 131.37 55.14 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.479 -0.763 . . . . 0.0 111.149 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -125.23 171.17 10.58 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 122.37 1.081 . . . . 0.0 110.307 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -108.18 115.02 29.35 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.7 t -111.61 121.5 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.8 163.15 24.8 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.915 0.864 . . . . 0.0 111.373 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -60.56 140.59 57.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.223 1.011 . . . . 0.0 109.484 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.73 -2.79 77.91 Favored Glycine 0 C--N 1.289 -2.043 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.8 t -94.48 149.35 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.093 -1.827 . . . . 0.0 109.154 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.533 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 30.1 p -95.18 145.87 24.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 85' ' ' CYS . 37.5 mt -54.95 -10.75 0.52 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.853 0.835 . . . . 0.0 108.891 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.605 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -83.96 -33.81 24.55 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.533 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp0 -70.97 -53.1 16.1 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.523 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -70.91 -29.28 65.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.805 -1.184 . . . . 0.0 112.379 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.81 23.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.092 -1.63 . . . . 0.0 110.126 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t -50.76 -21.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -20.0 20.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.382 -0.824 . . . . 0.0 110.493 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 15' ' ' LEU . 5.0 m-80 -99.58 11.69 38.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.57 34.61 73.53 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.07 -1.538 . . . . 0.0 110.334 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 15' ' ' LEU . 79.1 mt -115.22 -35.99 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.17 -1.194 . . . . 0.0 111.927 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.857 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -74.83 10.38 1.45 Allowed 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.144 -0.973 . . . . 0.0 111.94 -176.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.1 53.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.909 1.231 . . . . 0.0 111.641 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.857 ' N ' ' O ' ' A' ' 33' ' ' TYR . 36.3 mt -104.58 -83.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 36' ' ' VAL . 10.8 p -172.38 129.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.125 -0.984 . . . . 0.0 109.307 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.08 64.17 4.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.13 -72.22 0.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.189 -1.183 . . . . 0.0 109.837 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.6 p -96.24 -15.07 22.22 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 0.0 109.539 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.05 15.96 74.63 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.9 16.55 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -98.62 17.09 19.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.225 -1.162 . . . . 0.0 108.901 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.2 66.46 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.463 -0.773 . . . . 0.0 109.946 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.19 5.81 0.98 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' HG22 ' A' ' 47' ' ' THR . 2.0 p -143.86 -175.52 4.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 0.0 108.897 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -139.63 29.96 2.12 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.25 -0.906 . . . . 0.0 109.116 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.558 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.6 t -77.28 -30.91 54.5 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.6 p -78.64 37.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.92 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 26.6 t60 -69.48 113.58 6.91 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.296 -0.877 . . . . 0.0 109.522 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 177.03 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.68 -1.263 . . . . 0.0 108.511 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 74.2 m-85 -119.38 116.32 25.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.491 1.139 . . . . 0.0 109.491 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG13 HD11 ' A' ' 97' ' ' ILE . 4.0 t -89.12 131.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.044 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.7 t-20 -51.01 120.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.764 -1.21 . . . . 0.0 108.131 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -48.5 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.642 -0.662 . . . . 0.0 111.528 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.47 -14.2 41.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.513 -1.367 . . . . 0.0 111.197 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 94' ' ' LEU . 29.4 m-85 -116.62 -6.37 11.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.341 -1.475 . . . . 0.0 108.143 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 18.0 p -71.01 -38.2 72.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.97 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.92 5.69 45.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.007 -1.058 . . . . 0.0 110.359 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.5 mttm -112.17 -45.53 3.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.56 160.58 82.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.1 Cg_endo -57.18 116.9 3.54 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.196 1.931 . . . . 0.0 115.052 -176.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.77 129.66 2.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.362 1.077 . . . . 0.0 110.536 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 152.81 22.64 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.475 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -84.81 156.57 21.29 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.987 0.899 . . . . 0.0 110.545 -178.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.95 -11.83 6.53 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.664 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' O ' ' CE ' ' A' ' 70' ' ' MET . 11.3 mmm180 -72.43 -34.14 67.6 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.578 -1.326 . . . . 0.0 108.696 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' OE2' ' ND2' ' A' ' 64' ' ' ASN . 25.1 mp0 -72.28 -37.1 69.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.582 -0.699 . . . . 0.0 109.889 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -51.5 -40.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 109.013 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.6 -31.17 60.99 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.487 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 3.1 mpp? -79.8 -34.75 39.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.941 -1.329 . . . . 0.0 107.43 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' CD2' HD11 ' A' ' 78' ' ' LEU . 9.3 mt -57.35 -31.34 65.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -82.21 -9.34 59.54 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.669 -1.269 . . . . 0.0 108.855 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 12.02 37.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.654 -0.654 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.6 m -77.08 163.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.589 -1.319 . . . . 0.0 110.637 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.419 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 26.3 m -93.88 -19.36 21.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.605 -0.684 . . . . 0.0 111.764 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -98.68 178.9 4.85 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.158 -1.589 . . . . 0.0 110.485 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.16 128.61 36.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.571 -0.706 . . . . 0.0 110.166 -179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 71' ' ' LEU . 5.9 tp -82.06 158.0 23.92 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 122.751 1.262 . . . . 0.0 110.51 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 82' ' ' SER . 13.1 mmmt -120.76 157.85 53.49 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.962 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.93 -32.99 95.95 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.492 1.461 . . . . 0.0 109.487 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -106.24 21.28 17.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.945 -0.472 . . . . 0.0 109.907 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.03 145.6 55.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.34 -1.475 . . . . 0.0 109.015 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 57' ' ' THR . 1.7 mtp180 -157.04 141.11 16.3 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.518 -0.739 . . . . 0.0 109.415 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD23 ' S1 ' ' A' ' 107' ' ' FES . 8.0 mp -65.51 149.72 49.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 23' ' ' LEU . 1.6 t -87.69 -10.0 52.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 111.895 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.0 p -91.29 -24.2 19.91 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.2 -1.562 . . . . 0.0 111.476 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -92.03 18.32 8.13 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.508 -1.37 . . . . 0.0 110.132 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 60' ' ' VAL . 41.1 mm -112.37 126.85 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 121.76 -0.588 . . . . 0.0 109.994 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -101.24 122.16 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-O 121.23 0.538 . . . . 0.0 110.844 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.8 tpt -78.73 157.2 28.59 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 p -148.73 148.51 28.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.26 -42.32 67.33 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.623 1.548 . . . . 0.0 111.469 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.75 -37.44 73.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.078 -1.014 . . . . 0.0 109.772 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.0 mt -88.83 21.23 3.14 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.91 -1.119 . . . . 0.0 110.159 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.6 p-10 -56.75 139.27 51.28 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.798 -1.189 . . . . 0.0 109.743 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.16 -0.55 29.82 Favored Glycine 0 N--CA 1.505 3.267 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -54.68 129.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.534 -0.98 . . . . 0.0 111.378 -177.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.06 122.11 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.544 -0.723 . . . . 0.0 109.277 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.22 128.71 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.58 118.8 37.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.991 0.9 . . . . 0.0 109.342 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.55 126.9 28.86 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.7 Cg_endo -80.23 -171.72 1.32 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.901 1.734 . . . . 0.0 113.886 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -91.52 -14.31 30.6 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -123.89 111.68 16.35 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.4 pt20 -126.26 -29.59 2.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.436 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 29.7 m95 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.465 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 124.21 32.65 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -122.91 126.22 73.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 O-C-N 120.726 -1.234 . . . . 0.0 108.493 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.1 t -113.36 131.7 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.041 0.924 . . . . 0.0 109.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -109.64 119.59 39.87 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.89 114.92 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 p -76.72 -179.65 5.48 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.346 1.07 . . . . 0.0 111.269 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.16 -45.74 19.34 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -62.37 -7.37 4.29 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.469 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -13.08 61.34 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.31 129.89 40.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.878 -1.366 . . . . 0.0 109.863 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CG ' HH11 ' A' ' 12' ' ' ARG . 1.6 mtt-85 -103.41 137.91 40.86 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.004 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.575 HH11 ' CB ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -127.91 120.62 28.08 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.4 mt-10 -108.01 132.35 53.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.678 -0.639 . . . . 0.0 111.11 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -123.73 169.66 11.29 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 122.481 1.134 . . . . 0.0 110.123 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.99 113.3 26.7 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.674 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.4 t -109.25 121.51 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.9 161.07 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.925 . . . . 0.0 111.272 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -59.15 140.5 55.82 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.1 0.953 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.97 -1.34 86.89 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.798 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.674 ' HB ' HG12 ' A' ' 17' ' ' VAL . 59.3 t -93.84 150.12 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.847 1.824 . . . . 0.0 109.501 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 3.4 p -86.6 136.03 33.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.299 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 mt -47.67 -31.1 4.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.945 . . . . 0.0 109.258 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.5 tpt -71.95 -35.84 69.7 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 1.2 mp0 -58.32 -55.81 30.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 108.713 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.63 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.36 -25.79 67.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.763 -1.211 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.57 -64.96 0.74 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.933 -1.104 . . . . 0.0 110.285 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -51.91 -19.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.626 -0.671 . . . . 0.0 110.04 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -18.46 28.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -109.54 11.97 24.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.51 45.24 68.78 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.725 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.548 HD11 HD21 ' A' ' 15' ' ' LEU . 17.5 mt -114.84 -65.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.384 1.592 . . . . 0.0 113.511 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.548 ' OH ' HG22 ' A' ' 101' ' ' VAL . 15.7 m-85 -89.95 9.32 28.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.926 -1.109 . . . . 0.0 111.458 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 2.9 p-10 -57.71 -100.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.164 -1.585 . . . . 0.0 110.434 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 17.7 mm 40.88 54.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 t 63.19 107.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.286 -0.884 . . . . 0.0 109.243 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.84 132.09 10.85 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.03 -72.38 0.18 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.275 . . . . 0.0 109.863 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -98.55 5.67 47.71 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.055 -1.028 . . . . 0.0 110.523 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.78 -4.22 16.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.1 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.1 29.28 4.93 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 50.7 m -98.5 22.46 9.78 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.482 -1.011 . . . . 0.0 108.965 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.34 61.04 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -147.04 18.92 1.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 109.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.0 -168.84 2.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.822 -1.174 . . . . 0.0 109.914 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.04 6.02 6.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.0 m -53.57 -30.26 41.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.173 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.572 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 15.6 p -87.43 36.86 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 29.8 t60 -72.78 110.44 7.12 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -142.57 176.17 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.655 -1.278 . . . . 0.0 108.734 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.539 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 88.6 m-85 -123.28 112.19 17.33 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.949 0.88 . . . . 0.0 108.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.59 132.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 1.9 p-10 -52.56 121.39 6.99 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.468 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.73 -1.37 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.726 -0.609 . . . . 0.0 111.462 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.23 -16.62 39.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.703 -1.248 . . . . 0.0 110.979 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 94' ' ' LEU . 19.3 m-85 -116.41 -7.27 11.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.34 -1.475 . . . . 0.0 107.879 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.8 p -69.69 -44.43 70.45 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -82.15 -0.94 47.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.439 -0.788 . . . . 0.0 108.886 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CB ' HD21 ' A' ' 94' ' ' LEU . 45.7 mmtt -99.4 -47.69 5.06 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -80.29 152.22 73.22 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -42.35 110.61 0.16 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.456 2.77 . . . . 0.0 114.934 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -38.58 139.15 0.43 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.456 1.122 . . . . 0.0 111.213 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.481 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -59.45 131.99 52.63 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.409 ' OD1' ' CG ' ' A' ' 66' ' ' ARG . 5.1 p30 -83.62 172.22 12.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.163 0.982 . . . . 0.0 111.298 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.4 -21.81 27.53 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.256 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' CG ' ' OD1' ' A' ' 64' ' ' ASN . 33.9 mtp180 -68.21 -34.55 76.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.348 -1.47 . . . . 0.0 108.539 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.567 ' CG ' ' NE2' ' A' ' 87' ' ' GLN . 56.8 mt-10 -72.9 -42.39 63.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.606 -0.684 . . . . 0.0 110.389 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -52.01 -36.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 108.85 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.38 -33.99 27.04 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.304 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.9 mtm -79.97 -33.94 39.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.555 -1.556 . . . . 0.0 108.056 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 78' ' ' LEU . 16.3 mt -60.75 -28.26 68.57 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.55 -6.42 58.22 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.098 -1.001 . . . . 0.0 108.49 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.59 9.07 29.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.709 -0.62 . . . . 0.0 111.313 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.49 164.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.293 -1.505 . . . . 0.0 110.167 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.0 m -92.31 -26.08 18.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.964 -1.085 . . . . 0.0 111.603 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.86 -175.11 3.32 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.566 -1.334 . . . . 0.0 109.835 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.539 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.5 129.62 37.56 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.159 -0.963 . . . . 0.0 111.54 -177.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.527 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.7 tp -79.79 153.97 28.8 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 123.0 1.381 . . . . 0.0 111.158 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -117.53 156.51 49.22 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.83 -33.25 87.76 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 C-N-CA 120.928 1.085 . . . . 0.0 109.496 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -110.23 34.06 4.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.627 . . . . 0.0 110.529 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.8 m -61.57 143.23 56.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.464 -1.397 . . . . 0.0 110.189 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.53 HH22 ' HA ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -139.78 158.06 44.72 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.93 0.871 . . . . 0.0 111.143 -177.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.4 mm? -99.2 168.81 9.81 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.572 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 1.3 t -108.11 -9.14 15.64 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.021 -1.049 . . . . 0.0 112.528 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.2 p -100.99 -17.47 16.74 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.857 -1.152 . . . . 0.0 113.04 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.567 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 5.2 pt20 -107.76 19.9 19.51 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.952 -1.092 . . . . 0.0 110.673 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 84' ' ' LEU . 66.9 mt -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-O 121.615 0.722 . . . . 0.0 110.447 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.79 117.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.506 0.67 . . . . 0.0 111.182 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.3 tpt -76.05 156.99 33.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.662 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 p -150.81 147.46 21.07 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.75 -42.43 67.39 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.624 1.549 . . . . 0.0 111.501 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 5.4 pm0 -57.23 -37.55 72.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.145 . . . . 0.0 109.327 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.4 mt -89.17 22.2 2.91 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.163 -0.96 . . . . 0.0 110.184 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 22.5 p-10 -57.57 140.76 50.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.35 -0.844 . . . . 0.0 109.825 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.54 -1.86 34.47 Favored Glycine 0 N--CA 1.51 3.587 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.412 HG21 ' SD ' ' A' ' 90' ' ' MET . 16.3 tt -52.32 135.21 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.23 -1.159 . . . . 0.0 112.523 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.696 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.9 t -106.78 115.48 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.241 -0.912 . . . . 0.0 109.792 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.02 128.54 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.256 -0.902 . . . . 0.0 109.284 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.35 122.2 44.34 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.829 0.823 . . . . 0.0 109.325 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.8 t -106.79 131.37 21.75 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.751 -0.593 . . . . 0.0 109.618 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.32 -176.29 2.89 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.803 2.335 . . . . 0.0 113.497 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -89.51 -15.25 33.42 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.2 mmp_? -119.6 109.33 15.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -130.97 -33.08 1.58 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.534 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 22.1 mmtt -86.7 123.54 31.99 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.09 124.82 73.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.62 131.68 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.055 0.931 . . . . 0.0 109.725 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.42 118.73 37.41 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -99.82 114.49 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -75.67 179.54 5.32 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.373 1.082 . . . . 0.0 111.114 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.623 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.16 -43.86 27.55 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.59 -6.87 8.5 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.373 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.75 61.7 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.63 131.11 44.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.331 . . . . 0.0 110.051 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.66 136.11 43.97 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.331 0.586 . . . . 0.0 110.883 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ttm105 -131.02 127.28 37.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.8 mp0 -118.53 138.58 52.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.816 -0.552 . . . . 0.0 111.074 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -128.06 174.94 8.79 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 122.499 1.142 . . . . 0.0 110.156 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.94 114.75 28.9 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 21' ' ' VAL . 14.0 t -110.01 121.23 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.34 27.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.076 -1.015 . . . . 0.0 111.401 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.27 137.47 57.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.131 0.967 . . . . 0.0 109.543 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.68 -2.03 88.39 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.612 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 17' ' ' VAL . 99.4 t -95.69 149.22 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 119.784 -2.009 . . . . 0.0 109.341 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 4.3 p -87.88 139.65 30.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.5 mt -49.29 -33.94 14.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.977 -1.077 . . . . 0.0 108.933 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 85' ' ' CYS . 16.7 tpt -66.48 -37.26 84.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -60.65 -55.53 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.61 -27.5 67.75 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.628 -1.295 . . . . 0.0 111.473 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.29 -55.4 18.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.163 -1.586 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.0 -19.88 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.44 -0.788 . . . . 0.0 109.622 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -19.01 28.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.311 -0.868 . . . . 0.0 109.595 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.9 11.52 22.3 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.67 46.55 61.04 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.671 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.604 HD11 HD21 ' A' ' 15' ' ' LEU . 3.7 mt -114.81 -63.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 119.952 1.876 . . . . 0.0 113.699 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.59 ' OH ' HG22 ' A' ' 101' ' ' VAL . 25.0 m-85 -90.34 8.27 34.31 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.658 -1.276 . . . . 0.0 111.13 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 35' ' ' ILE . 1.6 p-10 -55.04 -98.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.535 -1.353 . . . . 0.0 109.22 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 34' ' ' ASP . 3.2 tt 33.11 88.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 36' ' ' VAL . 9.2 p 28.46 91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.104 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.42 138.94 19.12 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.27 -72.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.609 -0.936 . . . . 0.0 109.728 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.8 p -95.23 -3.02 48.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.092 -1.005 . . . . 0.0 110.464 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.87 60.09 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.65 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.07 25.84 6.28 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 121.232 -1.158 . . . . 0.0 110.326 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 13.2 t -98.01 18.26 16.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -1.154 . . . . 0.0 109.084 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB2' HE22 ' A' ' 87' ' ' GLN . . . 59.12 58.61 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.075 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 t -146.87 18.72 1.27 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.091 -1.006 . . . . 0.0 109.902 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.436 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.6 p -154.04 -168.46 2.96 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.861 -1.149 . . . . 0.0 109.813 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.9 11.73 4.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 19.3 p -64.14 -26.12 68.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.076 -1.015 . . . . 0.0 109.492 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.555 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 8.8 p -82.69 36.87 0.5 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.095 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.6 t60 -71.86 114.07 9.57 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -142.8 174.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 120.58 -1.325 . . . . 0.0 108.866 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 89.2 m-85 -121.0 112.98 19.43 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.316 1.055 . . . . 0.0 109.048 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG12 HD22 ' A' ' 53' ' ' ASN . 36.9 t -90.02 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.89 120.59 4.96 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.58 2.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.711 -0.618 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.99 -16.82 32.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.285 -1.509 . . . . 0.0 111.13 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -117.27 -8.27 11.12 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.59 -1.319 . . . . 0.0 108.326 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.0 p -69.22 -42.08 76.19 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.203 0.525 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.17 -3.43 54.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.807 0.813 . . . . 0.0 108.976 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -98.88 -45.39 6.01 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 94' ' ' LEU . 1.2 t -77.98 150.5 78.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.09 115.35 0.87 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 123.041 2.494 . . . . 0.0 114.287 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -44.71 143.29 1.43 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.926 1.346 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.61 50.71 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.893 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' ND2' ' OE1' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -82.78 169.88 15.65 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.692 0.758 . . . . 0.0 110.57 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.85 -16.28 6.38 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 66' ' ' ARG . 6.6 mtp180 -78.34 -37.67 43.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.202 -1.561 . . . . 0.0 109.069 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 14.4 mp0 -68.51 -42.79 78.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.564 0.697 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.2 mp -60.93 -29.93 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.521 -0.737 . . . . 0.0 110.065 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.54 -34.33 35.97 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 120.791 -1.193 . . . . 0.0 111.288 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 70' ' ' MET . 10.8 ptp -82.22 -32.92 29.53 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.31 . . . . 0.0 107.799 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.2 mt -62.36 -29.44 70.47 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.3 tp10 -76.48 -3.23 36.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.73 -1.231 . . . . 0.0 107.806 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.34 14.19 25.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.372 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -74.26 166.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.398 -1.439 . . . . 0.0 109.875 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.6 m -87.88 -22.9 24.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.641 -0.662 . . . . 0.0 111.094 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 104' ' ' ARG . . . -99.23 -176.88 3.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.686 -1.259 . . . . 0.0 110.061 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.02 130.45 40.98 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.634 -0.666 . . . . 0.0 110.596 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 6.9 tp -85.38 145.92 27.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.2 -1.563 . . . . 0.0 110.499 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 82' ' ' SER . 27.1 mmtm -108.11 159.17 31.58 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.38 -33.09 97.51 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.659 1.573 . . . . 0.0 109.168 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -109.46 24.84 12.53 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -67.93 148.52 50.98 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.641 -1.287 . . . . 0.0 108.802 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 62' ' ' ALA . 7.2 mmt85 -142.27 -168.42 2.72 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.417 1.104 . . . . 0.0 110.822 -177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -122.6 152.99 39.9 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -90.17 -4.65 57.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 111.615 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.2 p -110.95 -13.08 14.17 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.085 -1.009 . . . . 0.0 112.053 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.471 HE22 ' HB2' ' A' ' 43' ' ' ALA . 1.5 tp-100 -104.98 14.98 28.51 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.78 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.1 mt -110.72 124.41 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.422 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 mm -98.78 119.92 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.264 0.554 . . . . 0.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.456 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.1 tpt -77.27 156.42 31.41 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.85 0.833 . . . . 0.0 111.054 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -148.54 149.49 31.4 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.92 -40.06 81.3 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.667 1.578 . . . . 0.0 111.935 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.27 74.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.98 -1.075 . . . . 0.0 108.459 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 60' ' ' VAL . 10.2 mt -89.78 14.03 12.9 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.813 0.816 . . . . 0.0 109.572 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -57.18 140.97 48.0 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.32 -1.94 37.41 Favored Glycine 0 N--CA 1.505 3.263 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 53' ' ' ASN . 16.6 tt -51.22 133.03 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.279 -1.13 . . . . 0.0 111.58 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -105.45 112.26 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.456 -0.777 . . . . 0.0 109.213 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.26 127.17 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.383 -0.823 . . . . 0.0 109.742 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.59 121.72 42.96 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.652 0.739 . . . . 0.0 109.183 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG22 ' OH ' ' A' ' 33' ' ' TYR . 3.2 t -107.11 130.19 23.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.42 -173.15 1.63 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.315 2.01 . . . . 0.0 113.561 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.89 -16.41 28.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 mmp_? -118.94 110.5 17.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 -15.6 9.65 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 119.68 1.127 . . . . 0.0 108.29 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.407 ' O ' ' O ' ' A' ' 105' ' ' GLN . 70.2 t-105 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.33 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' NZ ' ' OE1' ' A' ' 14' ' ' GLU . 9.6 mmmt -85.73 116.26 23.89 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.134 -0.979 . . . . 0.0 109.034 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 17' ' ' VAL . 61.7 t -112.02 120.33 62.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 120.768 -1.207 . . . . 0.0 107.956 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -104.36 123.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.908 -1.12 . . . . 0.0 109.008 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.7 113.67 27.03 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.5 109.81 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 p -76.9 -175.38 3.47 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.096 0.95 . . . . 0.0 110.594 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.37 -44.25 19.72 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -63.58 -6.92 5.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 110.205 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.5 -13.65 62.63 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.637 -1.29 . . . . 0.0 110.695 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 127.54 31.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -1.202 . . . . 0.0 109.524 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.48 137.01 42.98 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.403 0.62 . . . . 0.0 109.564 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 125.18 33.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' OE1' ' NZ ' ' A' ' 2' ' ' LYS . 3.0 mt-10 -104.2 128.12 51.88 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.174 0.988 . . . . 0.0 109.696 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.56 160.85 20.05 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.552 1.168 . . . . 0.0 112.003 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -109.75 112.15 24.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.8 t -115.67 125.76 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.96 163.05 26.88 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.814 0.816 . . . . 0.0 111.017 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.18 143.41 57.82 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.319 1.057 . . . . 0.0 110.126 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.8 -2.08 75.7 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 40.8 t -92.95 149.79 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.529 -1.571 . . . . 0.0 109.414 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.8 p -94.42 143.95 25.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.264 -0.898 . . . . 0.0 108.664 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 90' ' ' MET . 60.9 mt -53.35 -20.05 4.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.88 -1.138 . . . . 0.0 108.969 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.401 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.6 ttt -78.8 -23.12 45.39 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.622 -0.674 . . . . 0.0 109.26 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.49 -54.77 5.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -25.91 62.92 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.823 -1.173 . . . . 0.0 111.866 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.7 65.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.63 -1.294 . . . . 0.0 111.044 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -75.43 -22.45 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.004 -1.06 . . . . 0.0 109.595 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -14.83 40.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.811 0.815 . . . . 0.0 109.419 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.26 11.39 25.4 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.56 76.85 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.952 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.1 mt -112.24 -38.1 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.856 -1.379 . . . . 0.0 111.643 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -68.23 13.69 0.08 Allowed 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.302 -0.874 . . . . 0.0 112.764 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.33 44.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 120.061 1.3 . . . . 0.0 111.576 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.828 ' N ' ' O ' ' A' ' 33' ' ' TYR . 26.2 mt -105.29 11.45 8.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 47' ' ' THR . 4.4 t 56.09 78.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.654 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.09 108.27 2.42 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -68.0 -65.24 0.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -1.071 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 9.1 p -66.27 -5.02 9.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.49 6.76 62.88 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 104.71 21.57 9.06 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.8 t -97.94 19.81 13.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.974 -1.309 . . . . 0.0 109.304 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.79 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -0.795 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.45 16.2 1.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.048 . . . . 0.0 109.829 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 5.8 p -146.78 -168.71 3.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.963 -1.085 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.89 24.34 3.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.139 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 35' ' ' ILE . 9.9 p -76.58 -23.29 53.49 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.325 -0.859 . . . . 0.0 109.369 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.0 p -90.09 37.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.335 -0.853 . . . . 0.0 110.95 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.75 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 22.5 t60 -71.89 112.9 8.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.21 177.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 98.7 m-85 -122.7 114.47 20.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.196 0.998 . . . . 0.0 109.241 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.676 HG13 HD11 ' A' ' 97' ' ' ILE . 59.6 t -89.22 130.58 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' ALA . 10.5 t-20 -49.5 121.94 5.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -49.02 -1.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 111.455 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.61 -14.64 34.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.254 -1.529 . . . . 0.0 111.025 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CG ' HG12 ' A' ' 97' ' ' ILE . 29.4 m-85 -113.87 -7.34 13.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.219 -1.551 . . . . 0.0 107.97 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -72.75 -38.1 67.48 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.897 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.49 -0.03 56.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.025 . . . . 0.0 110.383 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' LEU . 4.8 mtpp -107.16 -45.83 4.04 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -71.4 163.14 68.5 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 60' ' ' VAL . 11.1 Cg_endo -59.2 116.08 3.02 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.843 1.695 . . . . 0.0 114.48 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.14 131.9 1.42 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.416 1.103 . . . . 0.0 111.066 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.676 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -55.87 144.39 28.16 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.373 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -84.72 161.32 20.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.804 0.811 . . . . 0.0 110.199 -178.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.81 -19.22 16.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.901 -0.499 . . . . 0.0 111.27 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.01 -35.89 74.7 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.484 -1.385 . . . . 0.0 108.839 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' LEU . 24.2 mt-10 -73.85 -41.23 62.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 0.0 110.776 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -53.03 -34.04 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.697 -1.252 . . . . 0.0 108.943 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.53 -34.42 22.67 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.314 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 49.3 mtm -81.65 -33.24 31.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.485 -1.597 . . . . 0.0 108.056 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 82' ' ' SER . 2.9 tm? -68.87 -30.52 69.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -78.75 -3.45 44.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.862 -1.149 . . . . 0.0 107.951 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.9 13.87 28.82 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.895 -0.503 . . . . 0.0 111.135 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.12 172.44 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.438 . . . . 0.0 109.166 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 89.3 m -100.05 -18.32 17.06 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.884 -1.135 . . . . 0.0 112.475 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -91.28 -177.06 4.75 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.109 -1.619 . . . . 0.0 108.96 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -72.05 129.87 39.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.261 -0.899 . . . . 0.0 111.313 -177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.74 163.66 27.68 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.761 1.267 . . . . 0.0 109.707 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 82' ' ' SER . 38.6 mmtt -131.82 157.23 78.76 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.81 -35.36 58.71 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.202 1.268 . . . . 0.0 109.198 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -115.56 38.99 3.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 0.0 110.683 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.679 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -68.56 140.92 55.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.631 -1.293 . . . . 0.0 107.677 177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.676 HH21 ' N ' ' A' ' 63' ' ' ALA . 41.1 mtp180 -152.71 163.02 40.49 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.917 -1.114 . . . . 0.0 110.73 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.4 mt -87.08 164.96 16.14 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -106.91 -10.51 15.97 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.218 -0.926 . . . . 0.0 112.031 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.4 p -84.42 -26.68 28.12 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.558 -1.339 . . . . 0.0 110.726 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -95.6 13.46 26.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.747 -1.221 . . . . 0.0 110.25 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 mm -97.66 119.05 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.215 -0.928 . . . . 0.0 109.205 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.27 120.5 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.611 -0.681 . . . . 0.0 110.887 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -76.9 154.86 33.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.254 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -151.17 149.69 25.39 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.56 -42.22 67.68 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.658 1.572 . . . . 0.0 111.978 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -57.17 -38.96 74.39 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.013 -1.054 . . . . 0.0 109.656 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -89.05 17.25 5.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.978 -1.076 . . . . 0.0 109.489 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -53.71 138.23 35.72 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.585 -1.322 . . . . 0.0 109.317 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.29 -0.4 37.72 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.676 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -52.84 134.8 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.174 -1.192 . . . . 0.0 111.864 -176.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.596 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.7 t -104.37 112.77 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.176 -0.953 . . . . 0.0 109.591 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.505 HG22 HD12 ' A' ' 97' ' ' ILE . 2.1 t -100.17 126.26 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.016 -1.053 . . . . 0.0 109.436 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.57 116.14 32.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 t -104.43 130.68 22.85 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -81.19 -175.83 2.84 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.158 2.572 . . . . 0.0 114.425 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -88.33 -15.91 34.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -121.71 115.19 22.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' OE1' HD13 ' A' ' 35' ' ' ILE . 53.0 mt-30 -122.97 -23.3 5.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.535 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.22 -0.895 . . . . 0.0 108.723 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 2.3 mmmt -87.09 122.06 30.4 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.56 123.81 71.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 O-C-N 120.674 -1.266 . . . . 0.0 108.431 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.0 131.3 63.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.265 1.031 . . . . 0.0 108.833 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.57 120.04 41.29 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.01 110.15 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 p -70.63 177.03 3.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.227 1.013 . . . . 0.0 110.671 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.32 -41.84 47.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -65.47 -4.47 5.86 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.413 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.21 -16.44 61.29 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.92 137.62 53.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.739 -1.448 . . . . 0.0 108.92 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -112.3 137.9 49.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.393 0.616 . . . . 0.0 111.472 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.485 HH11 HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.22 127.4 39.55 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.657 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.1 mp0 -116.23 139.38 50.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.0 110.834 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -127.62 172.39 10.79 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.229 1.014 . . . . 0.0 110.273 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.84 114.02 27.67 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG12 ' HB ' ' A' ' 21' ' ' VAL . 2.3 t -111.96 124.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.7 159.31 28.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.154 0.978 . . . . 0.0 111.125 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -57.25 139.6 52.26 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.957 0.884 . . . . 0.0 109.518 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.03 -1.67 78.74 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.855 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.748 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.9 t -89.9 149.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.182 -1.775 . . . . 0.0 109.289 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 95.7 p -89.88 137.04 32.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.063 -1.023 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.5 mt -51.37 -25.1 5.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.129 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.0 tpt -75.35 -26.72 58.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.51 -56.08 5.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.459 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -65.72 -25.95 67.53 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.651 -1.281 . . . . 0.0 110.699 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -66.1 -63.55 1.06 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.381 -1.45 . . . . 0.0 110.015 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.24 -19.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.822 . . . . 0.0 109.523 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -90.43 -20.57 22.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.553 -0.717 . . . . 0.0 109.269 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m-80 -110.94 7.2 21.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.23 51.91 30.22 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.547 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.603 HD11 HD21 ' A' ' 15' ' ' LEU . 4.3 mt -110.78 -61.19 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.731 -1.452 . . . . 0.0 111.739 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.736 ' O ' ' N ' ' A' ' 35' ' ' ILE . 35.6 m-85 -82.86 24.71 0.72 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.758 -1.214 . . . . 0.0 112.541 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 27.9 p-10 -47.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.103 1.43 . . . . 0.0 111.023 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.736 ' N ' ' O ' ' A' ' 33' ' ' TYR . 47.5 mm -128.08 157.06 40.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 113.688 -1.597 . . . . 0.0 110.354 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 35' ' ' ILE . 66.2 t -42.62 -32.64 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.647 -0.658 . . . . 0.0 110.508 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 49.43 89.75 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -67.38 -69.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.343 -1.093 . . . . 0.0 110.157 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.1 p -68.4 -0.03 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 109.918 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.85 4.81 59.66 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.24 23.2 8.63 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.479 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 9.3 p -98.24 19.89 13.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.697 -0.884 . . . . 0.0 109.537 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.53 60.05 3.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 109.752 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.21 20.31 1.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.1 -1.0 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' N ' ' SD ' ' A' ' 70' ' ' MET . 4.4 p -153.47 -175.31 5.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.172 -0.955 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.32 32.55 5.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.541 -0.724 . . . . 0.0 109.269 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -87.72 -27.1 22.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.684 -0.635 . . . . 0.0 109.67 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' VAL . 6.6 p -84.07 37.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.436 -0.79 . . . . 0.0 110.67 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.674 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -65.05 111.56 2.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.411 -0.805 . . . . 0.0 110.364 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -138.68 176.14 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 O-C-N 120.588 -1.32 . . . . 0.0 108.173 178.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.555 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 90.2 m-85 -124.46 112.15 16.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.127 0.965 . . . . 0.0 109.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.89 133.37 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.772 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -52.87 121.63 7.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 4.7 pt-20 -49.38 0.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.719 -0.613 . . . . 0.0 111.622 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -87.65 -17.1 32.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.149 -1.594 . . . . 0.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -115.59 -7.27 12.19 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.538 -1.351 . . . . 0.0 108.177 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.4 p -69.68 -39.88 76.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.856 -0.527 . . . . 0.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -87.61 2.41 51.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 110.176 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -107.21 -45.23 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -68.88 162.82 61.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.715 ' HD2' HG22 ' A' ' 60' ' ' VAL . 9.8 Cg_endo -59.31 114.94 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.197 1.265 . . . . 0.0 113.003 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 61' ' ' PRO . . . -39.48 135.97 1.02 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.361 1.077 . . . . 0.0 110.151 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -62.91 146.77 52.13 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.835 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -84.39 160.87 20.54 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.91 0.862 . . . . 0.0 110.229 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.15 -13.55 1.28 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -32.13 53.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.241 -1.537 . . . . 0.0 108.924 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' OE2' HD22 ' A' ' 84' ' ' LEU . 4.7 tt0 -70.44 -43.95 68.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -54.01 -42.89 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.541 -0.725 . . . . 0.0 109.426 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.69 62.38 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.167 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 45' ' ' CYS . 33.9 mtm -79.29 -25.93 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.334 . . . . 0.0 108.073 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 78' ' ' LEU . 7.6 mt -70.38 -28.05 64.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 72' ' ' GLU . 9.0 tp10 -82.2 -13.08 57.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.753 -1.217 . . . . 0.0 108.348 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 9.98 39.13 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.778 -0.576 . . . . 0.0 110.016 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' LEU . 29.6 m -78.5 168.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.871 -1.143 . . . . 0.0 110.107 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.5 m -101.28 -12.53 18.61 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.101 -1.0 . . . . 0.0 112.009 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -103.27 -178.4 3.65 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.255 -1.528 . . . . 0.0 109.755 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.23 127.49 33.11 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.965 -1.084 . . . . 0.0 111.25 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 71' ' ' LEU . 4.6 tp -78.38 157.73 28.97 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.921 1.343 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -121.83 158.79 53.62 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.475 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.71 -37.82 95.02 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.321 1.347 . . . . 0.0 109.473 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -113.15 35.66 3.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.843 -0.536 . . . . 0.0 110.324 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -66.44 147.82 52.75 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.407 -1.433 . . . . 0.0 108.878 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -147.48 -169.68 3.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 111.302 -177.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.875 ' H ' HD23 ' A' ' 84' ' ' LEU . 1.1 pt? -139.15 177.66 7.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.863 -0.523 . . . . 0.0 109.81 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.1 p -108.62 -22.95 12.03 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.155 -0.965 . . . . 0.0 113.069 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.1 p -87.89 12.08 14.05 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.286 -1.509 . . . . 0.0 111.821 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 9.6 tt0 -138.25 15.54 2.8 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.677 -1.264 . . . . 0.0 110.467 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 19.1 mt -115.73 126.97 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 121.701 -0.625 . . . . 0.0 110.809 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.54 119.49 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.448 0.642 . . . . 0.0 109.808 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG21 ' A' ' 97' ' ' ILE . 6.0 tpt -72.77 156.34 39.02 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -153.92 150.89 23.66 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.9 -43.6 55.42 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.106 1.871 . . . . 0.0 112.767 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -60.3 -31.35 70.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.899 -1.126 . . . . 0.0 108.467 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 HG23 ' A' ' 60' ' ' VAL . 13.8 mt -90.31 8.45 33.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.492 -0.755 . . . . 0.0 109.582 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 29.9 p-10 -54.45 137.49 42.37 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.701 0.763 . . . . 0.0 109.746 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.88 35.14 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.434 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.1 tt -52.73 134.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.374 -1.074 . . . . 0.0 112.858 -176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.78 112.0 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.1 127.91 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.57 121.45 43.53 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.061 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 t -105.46 128.63 26.18 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.71 -171.96 1.29 Allowed 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.524 2.15 . . . . 0.0 113.53 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.76 -18.19 24.27 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -120.28 110.7 16.88 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -111.99 -9.22 14.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.757 -1.214 . . . . 0.0 108.615 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.417 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 58.8 t-105 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.485 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 10.0 mmmt -87.39 126.79 35.09 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.565 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.1 t -126.51 127.87 70.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 O-C-N 120.694 -1.254 . . . . 0.0 107.958 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.38 134.05 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.307 -0.871 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -108.75 118.39 36.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.6 111.9 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 p -75.6 -178.78 4.3 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.384 1.088 . . . . 0.0 111.29 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.629 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.77 -45.08 21.82 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -62.82 -5.25 2.65 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.435 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.19 65.68 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 132.3 46.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.027 -1.278 . . . . 0.0 109.288 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.55 138.98 41.74 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.406 0.622 . . . . 0.0 110.444 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -135.91 133.32 37.56 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.37 139.52 52.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.159 -0.963 . . . . 0.0 111.392 -177.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -127.96 175.31 8.47 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.324 1.059 . . . . 0.0 109.651 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.36 116.97 32.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 21' ' ' VAL . 1.7 t -112.02 122.33 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 161.02 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.038 0.923 . . . . 0.0 110.888 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.74 140.26 51.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.121 0.962 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.96 -0.01 74.09 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 17' ' ' VAL . 45.5 t -92.0 151.28 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.68 1.74 . . . . 0.0 108.897 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.9 p -91.32 138.71 31.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.6 mt -47.15 -27.95 1.63 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.556 ' SD ' ' CE2' ' A' ' 33' ' ' TYR . 10.3 ttt -69.99 -40.2 75.47 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' SER . 4.2 mt-30 -58.0 -55.61 32.74 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.166 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -64.99 -29.08 69.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.71 -1.244 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.43 -57.7 6.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 119.812 -1.805 . . . . 0.0 110.175 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -48.12 -22.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.984 -1.072 . . . . 0.0 110.048 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -21.03 20.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 110.316 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -101.12 12.39 37.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.111 -0.993 . . . . 0.0 108.936 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.04 35.08 71.08 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.997 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 HD21 ' A' ' 15' ' ' LEU . 28.6 mt -116.44 -31.38 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.742 1.271 . . . . 0.0 111.932 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.793 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -63.67 9.32 0.06 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.253 -0.904 . . . . 0.0 112.813 -176.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.06 35.62 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.683 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.793 ' N ' ' O ' ' A' ' 33' ' ' TYR . 10.9 pt -102.1 14.37 5.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.7 t 57.83 97.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.611 -0.681 . . . . 0.0 109.616 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.36 100.7 2.55 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.19 -68.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -1.144 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 42' ' ' SER . 12.3 p -64.49 -6.57 7.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.46 18.05 76.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.58 22.48 28.76 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.438 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 1.5 t -98.29 13.8 30.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.422 -1.046 . . . . 0.0 108.806 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.44 61.56 2.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.476 -0.765 . . . . 0.0 109.806 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.84 10.24 1.04 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.104 -0.998 . . . . 0.0 109.69 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 p -137.93 -168.45 2.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.342 -0.849 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.36 26.43 3.8 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.44 -0.788 . . . . 0.0 109.835 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' ILE . 81.3 p -81.56 -20.58 39.64 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 7.2 p -90.75 37.13 0.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.345 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 30.2 t60 -71.68 109.42 5.57 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.423 -0.798 . . . . 0.0 109.133 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.24 177.23 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.531 -1.356 . . . . 0.0 108.737 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 82' ' ' SER . 98.8 m-85 -122.89 115.2 21.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.433 1.111 . . . . 0.0 109.862 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 97' ' ' ILE . 88.0 t -87.46 129.19 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.859 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' ALA . 7.8 t30 -50.8 124.22 10.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.783 -1.198 . . . . 0.0 108.684 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -47.01 -5.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.955 -0.466 . . . . 0.0 111.246 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -84.8 -17.53 37.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.37 -1.457 . . . . 0.0 111.72 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -115.82 -4.97 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.237 -1.539 . . . . 0.0 108.234 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -69.75 -43.7 71.72 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.228 0.537 . . . . 0.0 110.127 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.09 -2.13 50.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.076 -1.015 . . . . 0.0 109.34 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -102.4 -47.3 4.52 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.768 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -71.29 153.6 94.07 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.8 Cg_endo -51.33 120.72 7.25 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.802 2.335 . . . . 0.0 114.162 -177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -39.27 129.56 1.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.433 1.111 . . . . 0.0 110.948 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.663 ' N ' HH21 ' A' ' 83' ' ' ARG . . . -58.21 145.89 35.76 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.257 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 5.2 p-10 -84.83 161.44 19.93 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.035 0.921 . . . . 0.0 110.414 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.4 1.43 3.91 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.292 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -81.84 -38.49 25.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.351 -1.468 . . . . 0.0 109.007 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -77.37 -30.81 53.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 0.0 110.677 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.9 mt -53.53 -38.58 33.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.999 -1.063 . . . . 0.0 109.393 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.07 -31.28 59.91 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 mtt -81.13 -35.33 31.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.985 -1.303 . . . . 0.0 107.924 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.5 mt -58.19 -29.8 65.93 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 10.4 tt0 -78.24 -1.61 33.8 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 10.13 26.01 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.88 168.12 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.327 -1.483 . . . . 0.0 109.955 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.4 m -87.46 -27.19 22.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.228 -0.92 . . . . 0.0 111.506 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -94.95 -176.75 3.94 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.703 -1.248 . . . . 0.0 109.037 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.555 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -75.08 135.69 41.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.365 -0.834 . . . . 0.0 111.08 -177.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 71' ' ' LEU . 5.7 tp -84.39 150.23 25.48 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.744 1.259 . . . . 0.0 110.045 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.0 mmtt -112.17 157.24 40.42 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.826 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.88 -33.46 98.62 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.002 1.135 . . . . 0.0 109.3 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -104.79 17.3 24.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.928 -0.483 . . . . 0.0 110.659 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -64.53 146.07 55.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.544 -1.347 . . . . 0.0 109.011 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.663 HH21 ' N ' ' A' ' 63' ' ' ALA . 36.1 mtp180 -151.5 154.75 37.15 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.14 169.47 18.14 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.326 -0.859 . . . . 0.0 108.892 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -106.8 -6.77 17.51 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.447 -0.783 . . . . 0.0 111.749 -178.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 12.5 p -94.08 -29.94 14.92 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.619 -1.3 . . . . 0.0 111.589 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 2.3 pt20 -93.84 13.12 23.52 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.405 -1.434 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 mm -96.8 118.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 119.63 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 6.3 tpt -75.43 157.92 33.42 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.238 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.45 151.3 23.65 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.18 -45.63 36.7 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.051 1.834 . . . . 0.0 112.592 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 1.3 pt-20 -56.99 -31.7 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 0.0 108.768 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 60' ' ' VAL . 6.9 mt -89.94 12.35 17.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.657 0.742 . . . . 0.0 109.974 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 25.2 p-10 -57.93 139.24 54.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.913 0.863 . . . . 0.0 110.522 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.21 41.63 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.438 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -56.82 140.18 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.51 -0.994 . . . . 0.0 112.548 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.5 118.2 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.642 -0.661 . . . . 0.0 110.708 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.63 126.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.426 -0.796 . . . . 0.0 109.241 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.74 118.5 37.07 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.718 0.771 . . . . 0.0 109.117 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 105' ' ' GLN . 19.0 t -104.29 131.67 21.69 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.644 -0.66 . . . . 0.0 109.346 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.59 -174.54 2.11 Favored 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.831 2.354 . . . . 0.0 114.44 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.53 -17.5 38.72 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.948 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.53 23.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.04 -13.97 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.527 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 70.6 t-105 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.259 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 24.6 mmtt -83.3 120.83 26.34 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.773 -1.205 . . . . 0.0 107.922 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 17' ' ' VAL . 54.6 t -117.98 123.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -115.25 134.82 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.965 0.888 . . . . 0.0 110.597 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 3' ' ' VAL . 91.9 m-85 -113.71 121.29 43.66 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.11 116.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 11' ' ' THR . 36.9 p -78.49 -178.26 5.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.265 1.031 . . . . 0.0 111.083 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -43.37 34.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -67.49 -7.8 28.52 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.268 -0.895 . . . . 0.0 110.61 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.0 60.27 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.692 -1.255 . . . . 0.0 110.626 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.428 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -70.63 128.52 36.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.682 -1.481 . . . . 0.0 109.765 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -106.04 141.15 37.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.538 0.685 . . . . 0.0 109.888 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.607 ' HD2' HD11 ' A' ' 32' ' ' ILE . 26.6 ttm105 -130.38 128.71 41.94 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.7 mt-10 -110.23 129.83 55.65 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -120.86 166.18 14.15 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.153 0.978 . . . . 0.0 109.783 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -103.4 115.58 30.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -111.25 123.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.801 -1.187 . . . . 0.0 108.005 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.49 161.63 30.23 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.348 1.07 . . . . 0.0 111.509 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 43.7 p-10 -60.22 139.67 57.44 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.189 0.995 . . . . 0.0 109.519 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.45 -2.22 88.12 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.37 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.3 t -95.92 148.58 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.001 -1.882 . . . . 0.0 109.319 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 12.0 p -87.68 142.11 28.09 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.938 -1.101 . . . . 0.0 108.905 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.2 mt -50.14 -40.38 46.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.033 -1.042 . . . . 0.0 108.976 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.438 ' SD ' ' CA ' ' A' ' 41' ' ' GLY . 4.4 ttp -60.93 -39.54 89.82 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.609 -0.682 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 22' ' ' SER . 30.6 mt-30 -58.77 -56.53 21.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 109.156 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.02 -26.32 67.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.864 -1.147 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.48 81.81 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.405 -1.435 . . . . 0.0 109.585 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.8 t -65.83 -20.88 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 109.951 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.28 32.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.184 -0.948 . . . . 0.0 109.325 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.7 17.11 20.97 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.99 57.02 21.05 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.943 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' HD2' ' A' ' 13' ' ' ARG . 83.9 mt -118.78 -55.08 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.041 -1.27 . . . . 0.0 111.539 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.29 9.38 25.82 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.3 -0.875 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 36' ' ' VAL . 2.0 p-10 -57.75 -98.19 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.572 -1.33 . . . . 0.0 109.225 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 15.2 mm 61.0 -67.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.272 0.558 . . . . 0.0 109.543 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 34' ' ' ASP . 40.8 t -142.34 -74.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.021 -1.049 . . . . 0.0 108.91 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.12 98.76 0.69 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.78 -72.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 110.461 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' SG ' ' N ' ' A' ' 42' ' ' SER . 7.2 p -73.46 -14.72 61.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.677 -1.265 . . . . 0.0 110.018 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.69 22.96 78.15 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.438 ' CA ' ' SD ' ' A' ' 24' ' ' MET . . . 91.24 19.4 42.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.425 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 3.4 m -95.37 12.75 28.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -1.11 . . . . 0.0 108.859 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.28 2.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.0 109.57 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.64 19.27 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -148.66 177.25 9.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.851 -1.155 . . . . 0.0 109.549 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -122.2 15.31 10.61 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 66.5 p -67.9 -30.88 70.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.561 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 4.3 p -75.0 39.05 0.13 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.67 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.9 t60 -70.95 107.77 4.22 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.44 171.83 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.915 -1.116 . . . . 0.0 108.259 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 94.6 m-85 -119.49 113.89 21.45 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.167 0.984 . . . . 0.0 109.294 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 97' ' ' ILE . 99.6 t -88.69 134.91 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 55' ' ' ALA . 8.0 t-20 -55.61 121.0 8.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.651 -1.22 . . . . 0.0 107.712 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -46.12 -2.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.652 -0.655 . . . . 0.0 111.793 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -85.69 -14.57 45.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.493 -1.379 . . . . 0.0 111.464 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CD2' HD22 ' A' ' 94' ' ' LEU . 28.3 m-85 -117.63 -6.12 11.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.11 -1.618 . . . . 0.0 107.785 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 p -68.09 -39.81 82.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.806 -0.558 . . . . 0.0 110.435 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -94.7 13.88 22.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -0.943 . . . . 0.0 110.146 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -118.23 -47.62 2.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -71.8 158.97 86.76 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.2 Cg_endo -54.03 115.65 2.5 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.959 1.773 . . . . 0.0 113.942 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.62 133.69 3.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 123.127 1.441 . . . . 0.0 110.573 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.605 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -65.1 147.08 54.12 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.546 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -74.39 151.78 39.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.608 0.718 . . . . 0.0 109.73 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.4 pm0 -69.34 -6.6 30.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.572 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 66' ' ' ARG . 3.0 mtm180 -73.24 -33.09 65.11 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.475 -1.39 . . . . 0.0 108.484 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 8.5 mp0 -79.31 -32.28 43.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.4 -46.83 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.673 -1.267 . . . . 0.0 108.237 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.74 -24.87 64.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.4 mtt -82.43 -33.93 28.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.346 . . . . 0.0 108.197 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.7 mt -58.51 -29.94 66.66 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -77.59 -4.21 44.71 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.659 -1.276 . . . . 0.0 108.357 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 8.76 28.13 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 0.0 111.253 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 46' ' ' ALA . 18.8 m -78.76 170.88 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.14 -1.6 . . . . 0.0 110.059 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.437 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -90.9 -24.42 20.21 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.378 -0.826 . . . . 0.0 112.161 -177.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -97.07 178.53 5.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.137 -1.602 . . . . 0.0 110.403 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.589 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.1 tt0 -69.98 130.71 42.92 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.607 -0.683 . . . . 0.0 111.29 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 71' ' ' LEU . 3.3 tp -77.55 156.89 30.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.658 1.218 . . . . 0.0 109.783 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.1 mmtp -119.64 158.47 49.33 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.058 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.93 -35.47 98.62 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.621 1.547 . . . . 0.0 109.288 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.32 29.86 7.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.878 -0.514 . . . . 0.0 110.166 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -62.66 147.55 49.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.813 -1.179 . . . . 0.0 108.063 178.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -147.75 165.45 30.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.558 -176.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -96.53 -179.38 4.59 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 4.2 t -116.73 -5.54 11.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.287 -0.883 . . . . 0.0 111.48 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -101.95 -33.07 9.89 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.813 -1.18 . . . . 0.0 112.216 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.682 ' NE2' HD23 ' A' ' 84' ' ' LEU . 6.1 pt20 -88.99 12.74 14.61 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.263 -1.523 . . . . 0.0 110.216 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 84' ' ' LEU . 81.9 mt -107.13 120.54 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.667 0.746 . . . . 0.0 110.629 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mm -98.67 122.11 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.7 tpt -79.25 158.18 27.64 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.343 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.3 p -150.03 148.62 25.37 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.66 -41.9 70.83 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.211 1.274 . . . . 0.0 111.33 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.12 -39.22 71.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.828 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.703 HD22 ' CD2' ' A' ' 56' ' ' PHE . 8.8 mt -86.86 22.35 2.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.167 -0.958 . . . . 0.0 110.654 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 43.8 p-10 -55.41 138.3 46.27 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.667 -1.27 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.69 -0.3 27.52 Favored Glycine 0 N--CA 1.512 3.763 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -53.82 128.71 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.392 -1.064 . . . . 0.0 111.658 -177.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.498 ' N ' HD12 ' A' ' 97' ' ' ILE . 24.0 t -105.97 118.2 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.827 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.06 128.66 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.66 123.04 46.26 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.548 0.69 . . . . 0.0 109.321 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -108.11 129.9 23.5 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.61 -0.681 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.58 -171.93 1.34 Allowed 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.703 2.268 . . . . 0.0 114.321 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -86.65 -17.48 33.69 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.04 114.63 19.34 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -113.55 -9.09 13.3 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 55.3 t-105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.057 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.494 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -83.25 119.02 24.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.15 122.12 68.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 120.974 -1.079 . . . . 0.0 108.176 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.99 132.27 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 122.03 0.919 . . . . 0.0 109.754 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -108.38 115.39 30.02 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.68 113.71 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.3 p -81.83 -176.03 5.89 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.237 1.018 . . . . 0.0 111.295 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -79.05 -43.45 24.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -64.15 -9.73 18.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.472 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.38 -9.19 59.08 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 120.932 -1.105 . . . . 0.0 110.537 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 HG21 HH12 ' A' ' 13' ' ' ARG . 0.6 OUTLIER -73.83 130.43 39.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.885 -1.362 . . . . 0.0 110.325 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 12' ' ' ARG . 1.4 mtm105 -99.38 131.68 45.23 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.581 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.453 HH12 HG21 ' A' ' 11' ' ' THR . 0.0 OUTLIER -124.09 120.3 31.99 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -111.96 132.61 54.66 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.261 -0.899 . . . . 0.0 111.914 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.62 170.28 11.11 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 122.267 1.032 . . . . 0.0 109.73 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.72 115.15 29.74 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 21' ' ' VAL . 13.9 t -112.45 124.48 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.37 164.13 26.84 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.404 1.097 . . . . 0.0 111.662 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -60.52 139.2 57.86 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.201 1.0 . . . . 0.0 110.18 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.64 88.79 Favored Glycine 0 N--CA 1.486 2.014 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.143 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 ' HB ' HG12 ' A' ' 17' ' ' VAL . 63.5 t -95.56 149.52 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.09 -1.829 . . . . 0.0 109.563 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.7 p -89.78 140.48 29.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.156 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.6 mt -52.04 -23.95 5.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.899 -1.126 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.5 ttm -77.82 -25.11 48.64 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -74.01 -57.89 3.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.12 -25.46 67.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.868 -1.145 . . . . 0.0 110.983 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -67.43 -57.18 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.695 -1.253 . . . . 0.0 110.133 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -49.48 -21.18 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.281 -0.887 . . . . 0.0 109.334 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -20.18 24.98 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.403 -0.811 . . . . 0.0 109.162 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 27' ' ' ALA . 5.4 m-80 -111.33 9.97 21.59 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.21 39.97 92.35 Favored Glycine 0 N--CA 1.503 3.159 0 C-N-CA 119.306 -1.426 . . . . 0.0 111.383 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 15' ' ' LEU . 70.4 mt -115.99 -60.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.796 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 1.7 t80 -87.33 5.34 39.0 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.82 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.613 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.4 p-10 -61.5 -91.31 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 109.411 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.468 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 26.2 mt 48.24 -82.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 34' ' ' ASP . 4.4 m -133.37 -166.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.101 -1.0 . . . . 0.0 108.881 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.07 95.63 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -68.22 -71.9 0.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -1.138 . . . . 0.0 110.972 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.1 p -74.71 2.8 9.14 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.035 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.95 -1.63 30.7 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.29 25.63 6.3 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.461 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 t -98.55 25.45 6.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -1.172 . . . . 0.0 109.191 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.15 60.62 3.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.611 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.75 17.67 1.28 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 4.4 p -150.99 -168.53 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.86 12.2 4.78 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.422 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 24.2 p -67.42 -21.49 65.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.155 -0.966 . . . . 0.0 109.4 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -88.31 36.98 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.047 -1.033 . . . . 0.0 110.683 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 32.9 t60 -70.19 112.25 6.4 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.579 -0.701 . . . . 0.0 111.21 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' CG1' ' OH ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -143.4 177.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 178.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 79.2 m-85 -124.69 109.65 13.41 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 122.424 1.107 . . . . 0.0 109.446 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 97' ' ' ILE . 63.4 t -85.05 136.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 55' ' ' ALA . 13.0 t-20 -54.93 119.65 5.71 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.579 -1.249 . . . . 0.0 107.87 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -46.99 -1.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.898 -0.501 . . . . 0.0 111.903 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -89.92 -12.79 37.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.297 -1.502 . . . . 0.0 111.243 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' HD22 ' A' ' 94' ' ' LEU . 24.7 m-85 -116.77 -7.46 11.48 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.492 -1.38 . . . . 0.0 107.526 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -70.91 -40.59 72.07 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.073 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.0 5.51 43.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.66 -1.275 . . . . 0.0 110.016 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 94' ' ' LEU . 7.7 mtpt -111.12 -44.66 3.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -69.68 160.02 81.46 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.9 Cg_endo -55.61 116.96 3.53 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.426 2.084 . . . . 0.0 115.079 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.53 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -41.12 131.75 2.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 122.359 1.076 . . . . 0.0 110.845 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.783 ' H ' ' NH2' ' A' ' 83' ' ' ARG . . . -68.62 -158.86 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.958 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -126.65 153.83 44.84 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.208 1.004 . . . . 0.0 111.054 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.58 -7.35 19.65 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -76.19 -30.49 58.06 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.521 -1.362 . . . . 0.0 108.056 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.64 -36.88 51.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.26 -44.17 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.65 -29.52 71.28 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.455 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.8 mtt -81.37 -36.71 29.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.865 -1.374 . . . . 0.0 107.714 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 78' ' ' LEU . 2.2 mt -61.51 -28.27 69.19 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -76.62 4.42 9.43 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.95 16.41 15.13 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.119 -178.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 m -73.77 166.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 120.39 -1.444 . . . . 0.0 111.636 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 106' ' ' TRP . 1.6 m -87.76 -28.11 21.91 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.326 -0.859 . . . . 0.0 110.603 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -102.21 -177.73 3.49 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.532 -1.355 . . . . 0.0 109.502 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -69.53 125.89 28.07 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.2 -0.938 . . . . 0.0 111.46 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 71' ' ' LEU . 7.3 tp -76.71 161.27 28.65 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.607 -1.308 . . . . 0.0 109.363 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 82' ' ' SER . 37.7 mmtt -122.15 157.51 57.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.22 -32.43 90.55 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 121.494 1.463 . . . . 0.0 109.397 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.94 22.55 15.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.736 -0.602 . . . . 0.0 109.928 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.19 150.47 47.45 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.541 -1.35 . . . . 0.0 108.939 178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.783 ' NH2' ' H ' ' A' ' 63' ' ' ALA . 21.2 mtp180 -151.97 160.08 43.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.675 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.1 147.89 24.72 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.15 -18.72 26.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.092 -1.005 . . . . 0.0 111.561 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.02 11.89 5.68 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.609 -1.307 . . . . 0.0 110.757 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -136.68 17.78 3.09 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.198 -0.939 . . . . 0.0 110.614 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG23 HG11 ' A' ' 60' ' ' VAL . 68.6 mt -109.84 125.13 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 O-C-N 121.484 -0.76 . . . . 0.0 110.438 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.7 mm -100.04 121.46 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.7 -0.625 . . . . 0.0 111.657 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.7 tpt -78.35 155.91 29.83 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.857 -1.152 . . . . 0.0 111.161 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.4 p -149.36 147.28 22.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.33 -42.84 64.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.531 1.487 . . . . 0.0 111.318 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -56.23 -36.56 68.62 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.805 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 59' ' ' LYS . 9.4 mt -87.6 21.94 2.4 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.786 -1.196 . . . . 0.0 109.694 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 19.6 p-10 -57.5 138.52 55.03 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.928 -1.107 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.28 -0.3 33.11 Favored Glycine 0 N--CA 1.503 3.144 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -54.96 133.38 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.265 -1.138 . . . . 0.0 112.652 -175.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.646 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.3 t -108.1 120.64 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.67 126.61 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.22 122.56 45.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.223 -0.923 . . . . 0.0 109.009 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.44 132.99 21.25 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.44 -172.53 1.51 Allowed 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.607 2.204 . . . . 0.0 114.165 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.2 -17.62 32.23 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.34 115.09 18.44 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 2.9 pt20 -116.78 -14.49 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.453 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 67.2 t-105 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.671 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 7.4 mmmt -88.6 122.12 31.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.039 -1.038 . . . . 0.0 108.27 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 1.7 t -119.45 123.7 71.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.69 131.2 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 122.117 0.961 . . . . 0.0 109.607 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -107.88 116.96 32.9 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.38 111.42 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -76.09 -179.06 4.74 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.248 1.023 . . . . 0.0 111.081 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.17 -43.14 34.94 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.38 -8.31 12.79 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.666 -0.646 . . . . 0.0 110.398 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.21 -10.61 63.61 Favored Glycine 0 N--CA 1.501 3.005 0 O-C-N 120.81 -1.181 . . . . 0.0 110.766 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.98 131.65 43.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.386 . . . . 0.0 109.597 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -99.38 130.6 45.66 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.262 0.553 . . . . 0.0 110.158 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -121.17 118.18 29.0 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.7 mp0 -110.04 131.33 55.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.817 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -127.43 174.49 8.97 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-O 122.159 0.981 . . . . 0.0 109.622 178.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.62 114.41 28.37 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 21' ' ' VAL . 16.9 t -109.25 122.49 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 156.8 34.37 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.283 1.04 . . . . 0.0 111.434 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.86 139.79 44.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.913 0.863 . . . . 0.0 109.557 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.48 80.44 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.557 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 17' ' ' VAL . 97.1 t -92.04 151.44 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 119.729 1.764 . . . . 0.0 108.798 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.96 136.93 32.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 25' ' ' GLN . 48.0 mt -49.61 -58.04 6.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.833 -1.167 . . . . 0.0 108.823 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.99 -20.05 0.47 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.603 -0.686 . . . . 0.0 109.155 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.8 tt0 -75.87 -63.53 1.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.351 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.71 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.985 -1.072 . . . . 0.0 110.856 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.667 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.52 -54.0 23.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -53.17 -20.63 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.925 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.64 -19.21 26.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.209 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -107.01 12.4 28.69 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.46 44.76 71.73 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.68 176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 5.3 mt -114.14 -63.09 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.076 -1.25 . . . . 0.0 113.049 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' HG22 ' A' ' 101' ' ' VAL . 12.6 m-85 -89.18 8.84 28.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.834 -1.166 . . . . 0.0 111.931 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.8 p-10 -57.37 -100.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.064 -1.647 . . . . 0.0 109.62 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 34' ' ' ASP . 1.6 pt 28.92 -90.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 121.262 0.554 . . . . 0.0 110.352 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 20.5 t -95.01 148.69 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 108.966 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.41 88.79 0.11 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.4 -71.91 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.177 -1.19 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 42' ' ' SER . 5.5 p -86.5 -5.39 59.16 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.116 -0.99 . . . . 0.0 110.228 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.14 6.15 64.0 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.671 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.03 22.13 8.12 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.505 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 11.7 t -97.83 18.74 15.1 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.115 -1.227 . . . . 0.0 109.114 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.42 57.72 3.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.02 24.0 1.18 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.987 -1.071 . . . . 0.0 109.51 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.69 -168.39 2.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.235 -0.916 . . . . 0.0 109.813 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -129.11 5.94 5.36 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.5 p -58.02 -22.51 50.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.379 -0.825 . . . . 0.0 109.444 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB2' ' H ' ' A' ' 85' ' ' CYS . 9.0 p -90.03 36.8 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.833 . . . . 0.0 110.084 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.642 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 23.8 t60 -73.97 114.56 12.41 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -144.83 179.91 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.729 -1.232 . . . . 0.0 109.195 179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 93.3 m-85 -125.01 111.09 14.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.259 1.028 . . . . 0.0 109.238 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.85 131.36 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 2.9 p-10 -50.41 121.34 5.54 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.291 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.76 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.692 -0.63 . . . . 0.0 111.52 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -89.02 -13.94 37.6 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.394 -1.441 . . . . 0.0 110.972 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 19.0 m-85 -117.93 -6.85 10.97 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.269 -1.519 . . . . 0.0 108.156 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 p -70.91 -38.39 72.96 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.634 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.8 11.87 23.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB2' HD21 ' A' ' 94' ' ' LEU . 12.5 mttm -118.55 -47.32 2.54 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.732 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -70.61 168.38 20.26 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.732 ' HD2' HG22 ' A' ' 60' ' ' VAL . 10.8 Cg_endo -61.48 111.53 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.283 1.137 . . . . 0.0 113.831 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.98 140.95 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.702 1.239 . . . . 0.0 110.986 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.6 137.46 54.28 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.679 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.76 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.46 169.59 16.22 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.994 0.902 . . . . 0.0 110.308 -177.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.82 -14.01 7.7 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' O ' ' CE ' ' A' ' 70' ' ' MET . 88.0 mtm-85 -78.45 -39.95 37.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 119.894 -1.754 . . . . 0.0 109.739 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 51.0 mp0 -65.02 -40.72 95.29 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.442 -0.786 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -52.36 -37.84 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -31.22 67.4 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.913 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mmt -80.53 -35.18 34.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.499 -1.589 . . . . 0.0 107.917 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 78' ' ' LEU . 8.1 mt -59.09 -33.52 70.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.498 -0.751 . . . . 0.0 109.045 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.47 -10.75 59.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 108.826 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.18 12.77 36.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.83 -0.544 . . . . 0.0 110.392 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.9 m -78.67 166.95 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.674 -1.266 . . . . 0.0 110.471 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.5 m -93.53 -19.61 21.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 111.708 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -100.58 -177.31 3.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.223 -1.548 . . . . 0.0 110.117 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.562 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -74.41 129.78 38.42 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.29 -0.881 . . . . 0.0 111.615 -177.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 5.2 tp -83.29 148.76 27.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.484 -1.385 . . . . 0.0 110.908 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 82' ' ' SER . 19.7 mmtp -110.93 159.94 30.7 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.51 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.74 -35.54 98.47 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.276 1.317 . . . . 0.0 109.079 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' C ' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -111.06 29.25 7.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.72 -0.613 . . . . 0.0 109.924 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -69.7 145.85 52.0 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.85 -1.156 . . . . 0.0 108.375 177.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.677 HH11 HD11 ' A' ' 88' ' ' ILE . 15.5 mmt85 -146.0 166.84 24.88 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.647 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.73 162.69 13.67 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' H ' ' HB2' ' A' ' 48' ' ' CYS . 3.7 t -97.19 -23.68 16.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.973 . . . . 0.0 112.071 -177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 31.5 p -87.38 -11.26 49.82 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.491 -1.381 . . . . 0.0 111.832 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 14.17 24.1 Favored 'General case' 0 N--CA 1.513 2.675 0 O-C-N 120.764 -1.21 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.677 HD11 HH11 ' A' ' 83' ' ' ARG . 17.5 mm -105.46 122.89 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-O 121.535 0.683 . . . . 0.0 110.442 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.34 117.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.487 -0.758 . . . . 0.0 110.243 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 97' ' ' ILE . 10.7 tpt -71.88 153.93 41.56 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.789 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.431 ' H ' ' HE3' ' A' ' 90' ' ' MET . 1.5 p -144.18 149.14 44.11 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.7 -43.53 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.569 1.513 . . . . 0.0 110.714 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.17 -35.68 75.9 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.245 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 59' ' ' LYS . 10.6 mt -90.73 17.66 7.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.11 -0.994 . . . . 0.0 110.337 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 21.6 p-10 -54.19 140.68 31.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.73 -1.231 . . . . 0.0 109.373 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -0.64 35.33 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.461 HG21 ' SD ' ' A' ' 90' ' ' MET . 17.6 tt -53.28 134.28 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 O-C-N 121.211 -1.17 . . . . 0.0 112.624 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.665 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 5.1 t -106.38 120.07 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.481 -0.762 . . . . 0.0 109.246 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.22 128.34 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -0.957 . . . . 0.0 110.159 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.5 121.68 43.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.994 0.902 . . . . 0.0 109.468 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' OH ' ' A' ' 33' ' ' TYR . 7.1 t -107.61 131.57 21.62 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 79.6 Cg_endo -82.1 -172.77 1.54 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.572 2.182 . . . . 0.0 114.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.4 -16.37 35.12 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 114.72 19.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -110.93 -7.75 14.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.373 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 6.1 mmmt -87.31 119.22 27.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.522 HG12 ' CE1' ' A' ' 5' ' ' TYR . 75.8 t -115.0 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 t -108.77 130.03 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.998 -1.064 . . . . 0.0 110.219 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 3' ' ' VAL . 91.4 m-85 -108.44 117.55 34.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.05 109.99 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 p -73.01 -179.67 3.34 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.129 0.966 . . . . 0.0 111.408 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -78.38 -44.88 23.83 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -64.51 -4.82 4.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.66 -13.85 64.84 Favored Glycine 0 N--CA 1.502 3.046 0 O-C-N 121.051 -1.03 . . . . 0.0 111.039 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.86 131.46 46.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.943 -1.328 . . . . 0.0 109.66 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -107.46 138.62 43.33 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.834 -0.541 . . . . 0.0 110.655 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttm105 -137.73 135.21 36.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.9 mp0 -115.73 136.51 52.99 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.293 0.568 . . . . 0.0 111.427 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 32' ' ' ILE . 81.3 mt -122.4 170.07 10.33 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.357 1.075 . . . . 0.0 111.864 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -108.16 107.71 18.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 ' HB ' ' A' ' 21' ' ' VAL . 15.9 t -107.54 120.94 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 163.57 22.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.077 0.941 . . . . 0.0 111.163 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.68 139.09 57.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 122.228 1.013 . . . . 0.0 109.796 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -1.89 69.3 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.181 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.3 t -90.8 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 119.469 1.635 . . . . 0.0 108.519 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -92.22 141.69 28.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.792 -1.192 . . . . 0.0 108.684 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 mt -52.99 -21.79 4.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.007 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -29.09 55.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -72.53 -52.91 13.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.4 -28.8 68.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.474 -1.392 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.23 68.89 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.345 -1.472 . . . . 0.0 110.629 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.87 -22.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.95 -1.094 . . . . 0.0 110.122 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -19.96 22.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.026 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.515 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.9 m-80 -103.0 12.11 36.47 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.81 33.65 71.08 Favored Glycine 0 N--CA 1.501 3.012 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.441 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 15' ' ' LEU . 28.5 mt -115.14 -34.47 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 O-C-N 120.809 -1.407 . . . . 0.0 111.488 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.878 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -73.71 11.31 0.86 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.914 -1.117 . . . . 0.0 112.661 -176.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -49.42 52.21 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 119.891 1.223 . . . . 0.0 111.466 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.878 ' N ' ' O ' ' A' ' 33' ' ' TYR . 70.1 mt -113.09 154.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -65.85 67.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.962 -1.086 . . . . 0.0 109.59 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ILE . . . -57.22 96.43 0.05 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -67.45 -57.41 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -1.096 . . . . 0.0 109.758 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -80.95 -2.44 47.74 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.859 -1.151 . . . . 0.0 110.023 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.55 7.4 68.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.14 22.76 10.31 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.463 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 32.3 m -98.27 20.52 12.38 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -1.012 . . . . 0.0 108.919 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.23 62.69 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.947 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.53 8.78 1.03 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.054 . . . . 0.0 109.558 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 70' ' ' MET . 4.7 p -140.24 -168.96 2.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.393 -0.817 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.12 31.79 2.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.787 . . . . 0.0 109.005 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -88.09 -22.43 24.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.57 37.94 0.76 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.481 -0.762 . . . . 0.0 109.945 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.414 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 18.7 t60 -68.42 116.61 9.18 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.456 -0.778 . . . . 0.0 109.985 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.28 173.8 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.936 -1.102 . . . . 0.0 108.104 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 75.6 m-85 -116.07 115.02 25.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 122.086 0.946 . . . . 0.0 109.121 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 97' ' ' ILE . 5.2 t -89.52 128.36 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 98' ' ' VAL . 4.3 p-10 -50.0 122.59 6.86 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.04 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -49.7 0.96 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.956 -0.465 . . . . 0.0 111.977 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -88.39 -16.41 32.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.69 -1.256 . . . . 0.0 111.395 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' HB2' HD13 ' A' ' 97' ' ' ILE . 66.8 m-85 -115.9 -8.48 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.616 -1.302 . . . . 0.0 108.17 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.0 p -68.5 -38.66 81.13 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.303 0.573 . . . . 0.0 110.186 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -87.94 -3.1 58.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.143 -0.973 . . . . 0.0 108.826 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -98.61 -48.84 4.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG23 HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -72.05 153.8 92.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.5 Cg_endo -54.31 122.58 11.76 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.648 2.232 . . . . 0.0 114.444 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -42.02 131.97 3.29 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.579 1.18 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' N ' ' NH2' ' A' ' 83' ' ' ARG . . . -57.02 157.24 6.0 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.095 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' OD1' ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -86.04 151.26 23.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.56 -16.55 6.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.82 -0.55 . . . . 0.0 110.543 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -74.07 -33.64 63.75 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -65.1 -39.68 93.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.743 0.782 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -59.63 -37.13 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.665 -0.647 . . . . 0.0 110.674 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 -35.35 53.57 Favored Glycine 0 N--CA 1.5 2.927 0 C-N-CA 119.273 -1.442 . . . . 0.0 111.898 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 45' ' ' CYS . 10.2 ptp -82.6 -32.79 28.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.74 -1.447 . . . . 0.0 108.123 177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 78' ' ' LEU . 2.0 tm? -70.2 -36.66 74.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 72' ' ' GLU . 20.8 tt0 -70.96 1.01 6.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 119.862 -1.774 . . . . 0.0 107.868 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -116.1 20.46 14.36 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.53 -178.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.59 172.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.183 -1.573 . . . . 0.0 110.527 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.413 ' OG1' ' OXT' ' A' ' 106' ' ' TRP . 4.0 m -98.01 -15.31 20.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.039 -1.038 . . . . 0.0 111.918 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 104' ' ' ARG . . . -97.33 177.01 5.69 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.428 -1.42 . . . . 0.0 109.491 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.494 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -67.76 129.18 39.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.845 0.831 . . . . 0.0 110.293 -179.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 71' ' ' LEU . 1.3 tp -72.94 166.72 22.49 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.518 -1.364 . . . . 0.0 109.927 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -135.08 154.34 78.97 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 -34.94 77.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 121.255 1.303 . . . . 0.0 109.388 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -111.39 33.71 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.782 -0.573 . . . . 0.0 110.499 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.01 143.45 50.78 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.485 -1.384 . . . . 0.0 108.814 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' N ' ' A' ' 63' ' ' ALA . 20.3 mtp180 -154.73 166.78 32.36 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.352 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 84' ' ' LEU . 10.5 mp -89.05 170.22 10.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.72 1.31 24.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.284 -0.885 . . . . 0.0 111.574 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.7 p -107.56 -27.26 10.48 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.862 -1.149 . . . . 0.0 111.044 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.532 ' NE2' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -89.78 17.9 6.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.864 -1.148 . . . . 0.0 108.808 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG23 HG11 ' A' ' 60' ' ' VAL . 8.0 mm -110.99 125.18 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-O 121.279 0.561 . . . . 0.0 109.942 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.92 122.67 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.562 -0.711 . . . . 0.0 110.442 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.849 ' SD ' HG21 ' A' ' 97' ' ' ILE . 7.1 tpt -78.23 160.43 27.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.555 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -152.93 151.68 26.79 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.33 -43.89 42.82 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.002 1.802 . . . . 0.0 112.634 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -60.24 -32.49 71.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.06 -1.025 . . . . 0.0 108.786 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.757 HD12 HG23 ' A' ' 60' ' ' VAL . 8.4 mt -88.6 14.16 10.56 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.793 0.806 . . . . 0.0 109.641 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.6 p-10 -58.88 138.77 57.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.145 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.91 34.46 Favored Glycine 0 N--CA 1.507 3.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.849 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -50.83 131.0 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.958 -0.731 . . . . 0.0 111.508 -177.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 4.1 t -104.6 113.96 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.707 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.42 127.07 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.298 -0.876 . . . . 0.0 109.385 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.86 119.29 38.58 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.091 0.948 . . . . 0.0 109.456 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.15 124.38 34.83 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 83.3 Cg_endo -81.35 -170.01 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 121.929 1.753 . . . . 0.0 113.848 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -92.35 -15.1 27.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -121.42 109.62 15.09 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' NE2' HD13 ' A' ' 35' ' ' ILE . 2.1 pt20 -123.17 -16.48 6.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.727 -1.233 . . . . 0.0 108.505 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.413 ' OXT' ' OG1' ' A' ' 75' ' ' THR . 75.2 t-105 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.102 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.404 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 23.5 mmtt -85.23 123.15 30.39 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG21 ' CG2' ' A' ' 17' ' ' VAL . 16.0 t -120.26 125.83 74.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 121.059 -1.025 . . . . 0.0 108.766 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.18 129.94 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.101 0.953 . . . . 0.0 110.077 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.85 120.48 42.62 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.07 112.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 11' ' ' THR . 34.4 p -72.2 179.58 3.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.001 0.905 . . . . 0.0 110.685 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -77.09 -42.39 38.34 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -68.53 -4.89 16.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.57 -12.67 59.74 Favored Glycine 0 N--CA 1.503 3.114 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.407 ' O ' ' OG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -68.94 129.16 39.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.971 -1.311 . . . . 0.0 110.169 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 12' ' ' ARG . 11.9 mtt85 -100.5 133.32 45.11 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HG2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -123.98 118.18 26.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' C ' HD23 ' A' ' 15' ' ' LEU . 15.5 mt-10 -106.69 129.28 54.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -122.7 169.86 10.64 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 122.169 0.985 . . . . 0.0 110.045 178.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.68 114.82 29.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG2' HG21 ' A' ' 3' ' ' VAL . 21.8 t -108.73 120.57 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 158.81 30.79 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 111.175 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -57.17 139.1 53.57 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.887 0.851 . . . . 0.0 110.251 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.08 1.4 79.73 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.49 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 17' ' ' VAL . 88.5 t -90.93 149.93 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.025 -1.868 . . . . 0.0 108.625 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 p -87.27 137.56 32.23 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.888 -1.132 . . . . 0.0 108.723 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -46.7 -39.05 10.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.944 -1.098 . . . . 0.0 108.808 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.504 ' SD ' ' C ' ' A' ' 24' ' ' MET . 8.1 tmm? -64.02 -41.09 97.56 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.595 -0.691 . . . . 0.0 109.664 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -55.52 -56.66 17.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -66.23 -26.33 67.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.968 -1.082 . . . . 0.0 111.075 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.05 76.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.732 -1.23 . . . . 0.0 110.279 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.85 -21.39 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.825 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -18.79 32.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.181 -0.949 . . . . 0.0 109.039 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -104.66 19.2 20.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.89 46.03 94.81 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.5 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HG2' ' A' ' 13' ' ' ARG . 96.8 mt -120.56 -40.91 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 120.948 -1.325 . . . . 0.0 111.321 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.15 2.05 42.65 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.281 -0.887 . . . . 0.0 111.299 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 36' ' ' VAL . 3.2 p-10 -70.56 -63.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 119.987 -1.696 . . . . 0.0 109.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 34' ' ' ASP . 17.4 tt -25.91 -38.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 34' ' ' ASP . 48.6 t -138.35 119.78 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.136 -0.977 . . . . 0.0 108.62 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.47 101.18 0.21 Allowed Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -75.73 -75.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.882 -1.363 . . . . 0.0 111.24 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.8 p -86.74 -3.75 59.09 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.875 -1.14 . . . . 0.0 111.147 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.99 13.0 75.77 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.38 -1.39 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.09 24.27 20.13 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.157 -1.202 . . . . 0.0 110.81 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 8.6 t -89.69 20.24 4.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 108.811 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 53.21 58.69 5.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.7 . . . . 0.0 109.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -150.05 26.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.114 -0.991 . . . . 0.0 110.268 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.3 p -161.47 -166.14 1.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.068 -1.02 . . . . 0.0 110.22 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -128.62 4.54 5.55 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 m -53.24 -19.7 3.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.967 . . . . 0.0 109.326 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.5 35.2 1.23 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 40.9 t60 -76.48 108.0 9.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.88 172.02 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.94 -1.1 . . . . 0.0 108.567 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.4 m-85 -118.23 114.53 23.16 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.526 1.155 . . . . 0.0 109.321 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 97' ' ' ILE . 12.6 t -92.33 132.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.325 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 55' ' ' ALA . 14.2 t-20 -50.76 117.17 2.32 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.01 -1.056 . . . . 0.0 108.406 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -48.06 -1.44 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 0.0 111.787 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -87.14 -12.95 45.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.557 -1.34 . . . . 0.0 111.001 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 94' ' ' LEU . 38.0 m-85 -117.63 -8.94 10.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.251 -1.531 . . . . 0.0 108.315 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.7 p -70.74 -39.29 73.4 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 21.9 p-10 -85.63 -0.31 54.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 108.648 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CB ' HD21 ' A' ' 94' ' ' LEU . 48.9 mmtt -100.45 -48.98 4.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -78.35 153.84 79.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.25 116.51 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.611 2.208 . . . . 0.0 113.701 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.43 149.11 2.38 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 122.605 1.193 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.63 54.65 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.781 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -74.94 166.64 23.34 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -61.3 -16.34 44.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.055 -0.403 . . . . 0.0 111.784 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' O ' ' SD ' ' A' ' 70' ' ' MET . 5.8 mtt180 -76.19 -35.09 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.319 -1.488 . . . . 0.0 108.238 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 36.1 mt-10 -69.68 -39.82 76.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.64 -0.662 . . . . 0.0 109.733 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.1 mt -56.29 -31.34 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.313 -0.867 . . . . 0.0 108.916 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.55 -33.38 38.81 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.2 mpp? -81.33 -32.42 33.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.763 -1.433 . . . . 0.0 107.734 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 78' ' ' LEU . 13.5 mt -62.67 -29.78 70.9 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -76.86 -4.34 43.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.821 -1.175 . . . . 0.0 107.929 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 14.67 28.5 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.768 -0.582 . . . . 0.0 111.203 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.455 HG12 ' HB1' ' A' ' 46' ' ' ALA . 27.2 m -78.27 163.75 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.412 -1.43 . . . . 0.0 112.04 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.57 -30.71 19.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.411 -0.806 . . . . 0.0 110.939 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -95.15 -177.71 4.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.266 -1.521 . . . . 0.0 110.766 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.547 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -68.91 123.26 20.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.406 -0.809 . . . . 0.0 110.402 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 71' ' ' LEU . 8.4 tp -76.9 152.45 35.36 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.685 -1.26 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 82' ' ' SER . 18.5 mmtp -112.29 157.37 40.18 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.98 -32.08 94.51 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 121.333 1.355 . . . . 0.0 109.503 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.1 p30 -107.97 23.2 14.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.012 -0.43 . . . . 0.0 109.935 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -65.58 147.49 53.32 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.419 -1.425 . . . . 0.0 108.948 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -138.16 178.91 6.77 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.681 0.753 . . . . 0.0 111.287 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.6 mt -114.78 114.83 26.1 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.66 -32.81 20.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.3 p -84.4 16.2 3.23 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.6 -1.312 . . . . 0.0 111.978 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.41 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 43.6 mt-30 -138.8 17.65 2.67 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 120.763 -1.21 . . . . 0.0 110.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.586 HG23 HG11 ' A' ' 60' ' ' VAL . 36.8 mt -112.9 126.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.02 119.35 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.514 -0.742 . . . . 0.0 110.46 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.912 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.2 tpt -78.09 160.01 28.33 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.153 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.8 p -150.6 149.26 25.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.14 -43.57 51.96 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.612 1.541 . . . . 0.0 111.442 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -56.46 -37.99 71.05 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.202 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 56' ' ' PHE . 9.2 mt -88.17 21.24 2.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.112 -0.993 . . . . 0.0 110.224 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 40.7 p-10 -57.67 141.13 49.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.483 -1.386 . . . . 0.0 109.987 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.19 -0.4 33.28 Favored Glycine 0 N--CA 1.504 3.196 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.912 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.4 OUTLIER -54.37 132.21 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.685 -0.891 . . . . 0.0 111.688 -176.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.92 118.56 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.527 -0.733 . . . . 0.0 109.679 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -108.15 129.66 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.962 . . . . 0.0 109.087 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.35 120.36 41.39 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.013 0.911 . . . . 0.0 108.922 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG12 ' HD2' ' A' ' 102' ' ' PRO . 4.0 t -94.18 151.13 39.35 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 101' ' ' VAL . 93.2 Cg_endo -99.72 179.84 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.433 2.088 . . . . 0.0 113.418 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 -21.66 27.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -132.72 120.76 22.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.505 ' NE2' ' H ' ' A' ' 106' ' ' TRP . 0.1 OUTLIER -129.54 -27.88 2.34 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.505 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.918 -1.039 . . . . 0.0 108.493 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_